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ABSTRACT

Transcriptional Regulation of the Shigella flexneri promoter:
Silencing and Anti-silencing by H-NS and VirB
by
Lieutenant Dustin John Harrison
Medical Service Corps
U.S. Navy
Dr. Helen J Wing, Examination Committee Chair
Assistant Professor of Science
University of Nevada, Las Vegas
Shigella species are gram-negative intracellular pathogens that cause bacillary
dysentery in humans. Many genes required for virulence of Shigella are carried on a
large 230 kb plasmid and many of these are under the transcriptional control of the
histone-like nucleoid structuring protein (H-NS) and by the major virulence regulator
VirB. At the non-permissive temperature of 30⁰C, H-NS represses transcription, while at
37⁰C VirB alleviates this repression. This mechanism of gene regulation has been coined
“silencing/anti-silencing” and is commonly found in many important bacterial pathogens
including Salmonella spp. and Yersinia spp. The icsP gene, encoded by the Shigella
virulence plasmid, is positively controlled by VirB and negatively by H-NS. The icsP
gene encodes an outermembrane protease respsonsible for maintaining the tight polar cap
of the actin polymerization protein IcsA, which is involved in the inter-, and intracellular
spread of Shigella.
Our work has revealed that sequences located over 1 kb upstream of the icsP
annotated transcription start site (+1) are needed for the VirB-dependent regulation of the
iii

icsP promoter. Using site directed mutagenesis we identified two DNA sequences that
are required for the VirB dependent regulation of the icsP promoter, both of which
display good matches to the reported consensus VirB binding site. We demonstrate that
sequences located upstream of position -665 relative to the annotated transcription start
site are needed for complete H-NS-mediated silencing of the icsP promoter.
Using electrophoretic mobility shift assays (EMSAs), and DNase I footprint analysis
we show that VirB and H-NS bind directly to DNA sequences located both upstream of 665 and downstream of -213 by and that these regions are predicted to display high levels
of intrinsic curvature. While we demonstrate that VirB functions to solely de-repress the
icsP promoter, our EMSA data indicate that VirB and H-NS are capable of binding to the
full upstream intergenic region (1232 bp) of the icsP gene simultaneously. These in vitro
data suggest that VirB may function to relocate H-NS bound to the region immediately
upstream of the icsP gene, rather than displacing H-NS from the DNA.
Our data also suggest that disruption of single regions of predicted curvature,
contained within the upstream intergenic region of icsP, does not have an effect on either
the ability of H-NS to silence the promoter or the ability of VirB to alleviate the H-NS
induced repression.
Taken together our data suggest that remote regulation of the icsP promoter requires
promoter proximal sequences that act in concert with upstream sequences. Our findings
raise the possibility that other bacterial promoters may be regulated by DNA-binding
proteins binding to remote DNA sequence elements. My work improves our
understanding of transcriptional silencing and anti-silencing, a regulatory event that
controls the expression of many virulence genes in many important enteric pathogens.
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CHAPTER 1
INTRODUCTION
The choreography of cellular processes is quite possibly one of the least understood,
and most interesting, challenges facing molecular biologists. These processes, e.g.
transcription, translation, replication, trafficking, and the myriad of mechanisms that
control and regulate them are central to understanding life, not only in eukaryotes but
prokaryotes as well. The regulation of just one of these processes, transcription, contains
multiple pathways designed to effectively control gene expression by down-regulating
the amount of gene products produced. At any one time, an organism only expresses a
fraction of its total potential, the rest is “turned off” (Yarmolinsky, 2000). There are two
ways in which a gene may be “turned off.” One way is repression, which is defined as
the binding of a protein at a promoter specific binding-site, which interferes locally with
RNA polymerase (RNAP) function (Yarmolinsky, 2000). The other way is by a process
termed transcriptional silencing, which can be defined as a process that renders
appreciable regions of DNA inaccessible to proteins such as RNA polymerase, DNA
modifying enzymes, etc., to which it would otherwise be able (Dorman et al, 1999,
Yarmolinsky, 2000). However, the distinction between repression and silencing seems
arbitrary and it is often difficult to distinguish the two, e.g. a silencing protein can
interfere with RNAP function but perhaps the specific binding site is not yet known.
Transcriptional regulation is a critical process that allows prokaryotic cells to quickly
adapt to constantly changing environmental conditions, nutrient concentrations, stress,
and antibiotics in order to exploite its desired niche.
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1.1 Transcriptional silencing
Gram-negative bacteria, like E. coli, contain at least 12 distinct types of nucleoidassociated proteins, each with its own expression pattern and DNA-binding differences
(Ali Azam et al, 1999, Dorman, 2004). These nucleoid-associated proteins (NAPs) are
direct DNA binding proteins that often have global influences on transcriptional
expression. Many NAPs are involved in down-regulating transcription while others are
involved in up-regulating transcription, and still others have the ability to do both. They
are often referred to as histone-like, however, this is based on the functional similarity to
eukaryotic histones and is not based on sequence or amino-acid similarity (Dorman,
2004). Like eukaryotic histones, many of these proteins have been shown to condense
DNA in vitro and in vivo. Although many types of NAPs exist the most extensively
studied is the histone-like nucleoid structuring protein, H-NS, its paralogue StpA, the
factor for inversion stimulation (Fis), the heat-unstable protein (HU), and the integration
host factor protein (IHF). My research has focused mainly on H-NS and its regulation of
the Shigella flexneri gene icsP.
The histone-like nucleoid structuring protein
H-NS is a small, 15 kDa, chromosomally encoded, protein with an intracellular
concentration of ~20 µM (Ali Azam et al., 1999, Bouffartigues et al, 2007, Spassky et al,
1984). The protein is expressed at a relatively constant level throughout the growth cycle
(Dersch et al, 1993). H-NS functions as a global repressor of gene transcription and is
responsible for the organization and higher-order structure of the bacterial chromosome
(Ali Azam et al., 1999, Dorman, 2004). The concept of transcriptional silencing by HNS arises from the observations that certain operons in E. coli and Salmonella are under
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the negative control of this protein, with the important H-NS binding regions being
located outside of the canonical promoter sequences (Goransson et al, 1990, Higgins et
al, 1988). It was shown that the presence of H-NS formed a barrier to gene expression
that was not easily overcome by either point mutations or small insertions into the regions
to which H-NS was shown to bind (Schnetz, 1995, Yarmolinsky, 2000). Furthermore it
was suggested that silencing occurred as a result of H-NS interacting with sequences
located both upstream and downstream of the genes studied, and then interacting with
itself to form looped structures (Schnetz, 1995). Also, it has been proposed that binding
of H-NS to DNA affects the superhelicity of bacterial promoters, thereby modulating
transcription. H-NS has also been proposed to be an environmental sensing molecule
modulating gene expression in response to changes in DNA superhelicity as a result of
temperature, pH, osmolarity, and growth phase (Atlung & Ingmer, 1997, Fang & Rimsky,
2008, Dorman, 2004,). While evidence suggests that the relationship between H-NS and
changes in environmental conditions is complex, it is clear that H-NS is not simply a
temperature or osmolarity sensor (Fang & Rimsky, 2008).
While numerous examples of H-NS induced silencing exist, it is unclear if H-NS can
act directly as a transcriptional activator. Accounts of H-NS functioning as an activator
have been described, for example, in E. coli H-NS has been shown to positively affect
flagellum biosynthesis (Bertin et al, 1994, Soutourina et al, 1999) and H-NS has been
shown to act as a positive regulator of pectate-lyase synthesis in the plant pathogen
Erwinia chrysanthemi (Nasser & Reverchon, 2002). However in both instances, H-NS is
functioning indirectly as an activator by directly repressing a repressor, thus eliciting a
net positive effect.
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Interaction of H-NS with DNA
The ability of H-NS to function at the multitude of promoters as it does, arises from
the fact that H-NS does seem to bind to just one consensus binding sequence, but rather
H-NS displays binding affinity for a particular DNA structure; curved DNA (Dame et al.,
2000, Lang et al., 2007, Bouffatrigues et al., 2007, Dorman, 2004, Spassky et al., 1984,
Zhang et al, 1996, Zuber et al, 1994). Curved DNA is commonly found in promoter
regions regulated by H-NS (Yamada, 1990, Bracco et al., 1989, Jauregi et al., 2003).
The intrinsic curvature of promoters can be specified by a variety of DNA sequences
(Pedersen et al., 2000, Barbic et al.,
2003a), which allows DNA binding
proteins that recognize such structures
the ability to interact with a variety of
promoters, but are often caused by AT
rich regions of DNA. DNase I footprint analysis of H-NS binding has demonstrated HNS interaction with AT rich DNA time and again (Dame et al, 2005, Dame et al, 2006,
De la Cruz et al, 2007, De la Cruz et al, 2009, Dorman et al, 1999, Dorman & Deighan,
2003, Dorman, 2004, Dorman, 2009, Porter & Dorman, 1994, Rimsky et al, 2001,
Rimsky, 2004, Shi et al, 2004, Stoebel et al, 2008, Williams et al, 1996, Turner &
Dorman, 2007). New insights into the transcriptional regulation by H-NS have yielded a
10 base pair (bp) consensus binding site (Fig. 1) at the osmoregulated E. coli proU
promoter, which regulates an osmoprotectant uptake locus (Lang et al, 2007). This site is
found in two positions downstream of the proU promoter, termed the negative regulatory
element (NRE). This binding motif has been proposed to be a nucleation site for H-NS
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binding. Upon binding by H-NS, these high-affinity sites are thought to act
synergistically with lower affinity sites located in the promoter which allows the
formation of a specific nucleoprotein complex that results in the repression of
transcription (Fang & Rimsky, 2008, Bouffartigues et al., 2007, Lang et al., 2007).
While promoters such as the E. coli bgl promoter contains 10 potential such binding sites,
others like the E. coli nir promoter contain less (Fang & Rimsky 2008), and still some
promoters contain no such sequence yet bind H-NS in vitro. Whether the high-affinity
binding site is present or not, it is clear that upon H-NS binding to DNA, it spreads, or
oligomerizes, along the DNA, coating it.
Structure of H-NS
To understand how H-NS oligomerizes on DNA one must first understand its
structure. While the complete crystal structure of H-NS has not been resolved, proteomic
analysis (primarily Nuclear Magnetic Resonance [NMR]) has revealed some interesting
findings regarding H-NS. The H-NS protein is 137 amino acids in length and is
comprised of three structural components: an N-terminal oligomerization domain; a Cterminal DNA binding domain; and a flexible linker that connects the two (Rimsky 2004,
Dorman 2003, Dorman 2004). A 46-residue segment of the N-terminal domain was
found to be required for dimerization (Bloch et al, 2003). NMR analysis of the E. coli HNS protein showed that the resulting structure was an intertwined anti-parallel structure
that resembled a “handshake” (Bloch et al, 2003). Interestingly, the same structure from
the corresponding region of the protein from Salmonella typhimurium showed a parallel
arrangement (Esposito et al., 2002). It should be noted that both proteins have identical
amino-acid sequences, and remains unclear as why both proteins adopt different
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structural configurations (Esposito et al., 2002, Rimsky, 2004, Dorman, 2000). The Nterminal structure of VicH, the H-NS-like protein from Vibrio cholerae, shows similar
structural features to that derived from E. coli, which highlights the conserved function of
this region (Cerdan et al, 2003).
Unlike differences in the N-terminal domain, the C-terminal nucleic acid binding
domain remains highly conserved among members of the H-NS family (Tendeng &
Bertin, 2003). Mutations in the C-terminal, DNA binding, domain do not impair the
proteins ability to dimerize, but instead impairs the ability to recognize curved DNA
(Bloch et al., 2003). This indicates a role for the C-terminal domain in DNA binding but
shows that DNA binding activity is dependent upon the N-terminal domain, which allows
dimerization, initiating the DNA binding event (Dorman, 2004, Ueguchi et al, 1996).
Experiments using modified H-NS proteins lacking oligomerization properties lack the
ability to bind DNA, and therefore lack the ability to induce repression. This supports the
findings that oligomerization of the protein is required for full activity of H-NS (Rimsky
et al., 2001, Badaut et al., 2002). In solution H-NS forms a dimer, although higher
oligomeric states have been observed dependening upon the concentration of H-NS
(Smyth et al, 2000, Rimsky, 2004). The higher-order oligomerization, which is an
essential function of H-NS, is a function of the flexible linker region of the protein (Bloch
et al., 2003). Disruption of the flexible linker region impairs the ability of H-NS to form
higher-order oligomers, implicating this region in higher-order structure formation
(Esposito et al., 2002).
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Fig. 2. From Dorman, 2004, showing two views of H-NS-mediated DNA bridging. a) H-NS dimer
interacts simultaneously with two DNA duplexes or different parts of the same duplex through its Cterminal domains, based on the model by Esposito et al. (2002) for the Salmonella protein showing the N
terminus lies parallel to the C terminus. b) Two H-NS dimers, each bound to separate DNA duplexes (or
separate parts of the same duplex) interact with each other via their extended flexible linker regions. It is
proposed that extension of the linker region is brought about by simultaneous involvement of the Nterminal and C-terminal domains in DNA binding. This model is based on analysis of the E. coli protein
(Rimsky, 2004). The promoters within the dimers are shown in dark green and light green. N = aminoterminus, C = carboxy-terminus.

H-NS silences transcription by altering DNA topology
Based on the structural data available two proposals have been made regarding the
mechanism of H-NS function. The first proposal, based on the Salmonella typhimurium
H-NS protein, suggests a role for head-to-tail dimers, where the unstructured flexible
linker region allows the cross-linking of separate DNA duplexes or different parts of the
same duplex (Esposito et al., 2002, Dorman 2004) (Fig. 2a). The second proposal, based
on the E. coli H-NS protein, suggests that the N-terminal and C-terminal interaction with
7

DNA imposes a more stable structure on the flexible linker, which allows it to interact
with the flexible linker region of other bound H-NS molecules which results in a higherorder, cross-linked, nucleoprotein complex being formed (Esposito et al., 2002, Dorman
2004)(Fig. 2b). Atomic force microscopic analysis supports this second proposal that HNS can cross-link DNA in this manner (Dame et al., 2000).
Either mechanism could contribute to the H-NS condensation of DNA. H-NS has
also been shown to bind at a region of curvature to which it nucleates, followed by
oligomerization along the DNA (Amit et al, 2003). In this model of transcriptional
silencing the curved sequence to which H-NS binds is located upstream or downstream of
the promoter, which acts as a nucleating site
(Rimsky et al., 2001). The initial
protein:DNA interaction at a bent region
induces an intramolecular bridge. The
formation of the intramolecular bridge
further stimulates H-NS mediated bridging of
the flanking sites resulting in oligomerization
(Dame et al., 2000). H-NS oligomerization
along the DNA in either direction from

Fig. 3. From Mauer et al., 2009. H-NS induced
plectonemes. H-NS bound to lambda DNA at a
ratio of 1 H-NS molecule per 1539 bp. The two
DNA duplexes in the H-NS “filament” adopt a
tightly interwound plectonemic form.

nucleating sites is not in conflict with the
previously described modes of action for H-

NS, as additional higher-order nucleoprotein complexes could form between multiple
regions of DNA bound by H-NS separated by un-bound, intervening DNA (Kim &
Wang, 1999). Interaction of two sites of H-NS bound DNA has been shown to trap RNA
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polymerase at the promoter, preventing transcription (Dame et al., 2002). Therefore, the
regulation of promoter activity is much more complicated involving the arrangement and
multiplicity of nucleation and propagation sites (Rimsky, 2004), followed by bridging of
two DNA helices and subsequently, condensation (Dame et al., 2000, Maurer et al,
2009).
The alignment of the H-NS dimers effectively “zippers” the DNA, constraining
negative supercoils, thus changing DNA topology, which results in transcriptional
silencing (Rimsky et al., 2001, Tupper et al, 1994). Nucleoid-associated proteins binding
to DNA can alter the topology of the DNA into two basic types of coils: either
plectonemic (interwound) or toroidal (solenoidal) (Maurer et al., 2009). Binding by HNS results in plectonemic (interwound) structures that are capable of covering at least
1.65 kb (Maurer et al., 2009) (Fig. 3). Atomic force microscopic analysis of H-NS bound
DNA, showed that H-NS-DNA complexes were organized into consistent structures and
that the periodicity of H-NS binding induced structures was approximately every 60 bp of
DNA (winding two DNA duplexes together, onto themselves) (Maurer et al., 2009). The
heat-unstable protein (HU), another NAP, that exists as an octamer, and which has been
shown to antagonize H-NS, has been measured to bind to approximately 64-68 bp
(Broyles & Pettijohn, 1986). This suggests that one conformation (e.g. plectonemic)
could be easily converted into another (e.g. toroidal) simply by reorganizing the
nucleoprotein complex by the interaction of a competing protein. This explains how a
competing DNA binding protein might function to relieve H-NS induced repression, at a
mechanistic level. These tight plectonemic structures stabilized by H-NS are consistent
with gene silencing and repression (Maurer et al., 2009), therefore, the promoters of the
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regulated genes should then be located at the nodes where they would remain accessible
to transcriptional machinery, however, direct evidence for this is lacking (Rimsky, 2004).
In these topologically closed domains, the plectonemic conformations of the DNA can be
easily overcome by other NAPs or RNA polymerase (RNAP), as the force with which HNS constrains DNA is relatively weak, ~ 7pN while the force generated by RNAP is up
to 25 pN (Dame et al., 2006, Maurer et al., 2009). The ease with which these structures
can be overcome ultimately results in transcription.
A plectonemic structure constrained by H-NS, and a simple conversion to a toroidal
or open conformation, by another DNA binding protein, or a change in DNA
superhelicity subsequent to changes in osmolarity or temperature (Adler et al, 1989),
satisfies the requirements that the DNA i) remain accessible to transcriptional machinery
and ii) maintains the bacterial nucleoid by compacting the DNA (Dame et al., 2006,
Maurer et al., 2009). We are beginning to build a more complete mechanistic picture of
the way in which silencing is achieved.
H-NS interaction with other nucleoid-associated proteins
The oligomerization domain of H-NS is not only important for H-NS:H-NS
interactions, but also facilitates binding with heterologous proteins that share the same
domain (Dorman, 2004). Studies have shown that H-NS can oligomerize with up to five
different protein species in the H-NS family (Rimsky, 2004, Dorman, 2004).
Oligomerization by H-NS to other related proteins raise the possibility that the activity of
these heteromers is altered resulting in additional levels of complexity in gene regulation
((Dorman & Deighan, 2003), Rimsky, 2004). The most common of these other
heterologous proteins is the paralogue StpA (Rimsky, 2004, Dorman, 2004). StpA has
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been described as a molecular back up for H-NS, however, it does not always provide
this function (Dorman & Deighan, 2003). StpA shares many properties with H-NS
including, 52% homology, the DNA binding domain, oligomerization domain and a
flexible linker connecting the two (Zhang et al., 1996, Ueguchi et al., 1996, Williams et
al., 1996, Spurio et al, 1997, Dorman et al., 2000, Smyth et al., 2000). Each protein can
inhibit its own expression as well as the expression of the other protein (cross and
autoregulation) (Zhang et al., 1996). It has been proposed that StpA acts as a molecular
adapter facilitating targeting of H-NS to DNA by multiple protein:protein interactions
(Free et al, 2001). Some bacteria express more than one member of the H-NS family, an
example is Shigella flexneri that expresses 3 members: H-NS, StpA, and Sfh, and all
three proteins can form oligomeric complexes with each other (Deighan et. al., 2003). Of
the H-NS-like proteins studied thus far, all have the ability to form protein:DNA bridges
(Dame et al., 2005). The resulting complexes in all theses previously described situations
leads to transcriptional silencing.
H-NS has also been shown to interact with other, more distantly related proteins. HNS interaction has been described with the: FliG flagellar motor protein, Hfq which binds
RNA and modulates translation of mRNA, Hha a thermo-osmoregulator of the E. coli αhaemolysin toxin, and the Yersinia enterocolitica Hha homologue YmoA (Donato &
Kawula, 1998, Dorman, 2004, Nogueira & Springer, 2000, Ellison & Miller, 2006a,
Ellison & Miller, 2006b, Stoebel et al., 2008).
Together, these findings suggest that protein-protein interactions of this nature are
widespread in gram-negative bacteria. Interestingly, the genes that encode H-NS-like
proteins and the Hha-like proteins are found on plasmids acquired by horizontal gene
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transfer (Dorman, 2004). One hypothesis for why a plasmid would carry its own H-NSlike protein is that it appears to protect the recipient cell from the deleterious effects of HNS titration by AT-rich sequences and allows the cell to tolerate the plasmid (Doyle et al,
2007).
H-NS silences genes acquired by horizontal gene transfer
Horizontal gene transfer has been described as one of the primary sources of genetic
diversity in microorganisms (Jain et al, 2002) and has been most extensively studied in
the human bacterial pathogens where many virulence factors have been acquired in this
manner (Hacker & Kaper, 2000). Acquiring genes through horizontal transfer raises
some very important regulatory issues, e.g. will the new gene be incorporated
immediately into existing regulatory circuits? Will the gene operate independently?
Foreign sequences are more likely to decrease the fitness of the host rather than
increasing it (Navarre et al, 2006). Therefore, incoming, newly acquired sequences must
be brought under the control of existing cellular regulators, and it is the proteins that
show the highest degree of promiscuity for promoters that are best adapted to this
function, e.g. H-NS (Dorman, 2004, Navarre et al., 2006). The silencing of newly
acquired genes by H-NS is thought to protect the bacterium from potentially deleterious
effects of transcribing genes that may compromise their fitness (Navarre et al., 2006).
Many examples exist in the literature of H-NS mediated silencing of genes acquired by
horizontal gene transfer, for example the large, 230 kb, virulence plasmid of Shigella and
enteroinvasive E. coli which carries many of the genes required for virulence, like a type
III secretion system (t3ss) and genes required for invasion and adhesion (Adler et al.,
1989, Beloin & Dorman, 2003, Beloin et al, 2003, Hromockyj & Maurelli, 1989,
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Hromockyj et al, 1992, Porter & Dorman, 1994). Similarly H-NS has been shown to be a
repressor of the virulence genes associated with the Salmonella SPI-1 pathogenicity
island, the virulence regulon in Vibrio cholerae, the invasion gene invA of Yersinia, and
the locus of enterocyte effacement (LEE) pathogenicity island of enteropathogenic E. coli
(Tupper et al., 1994, Porter & Dorman, 1994, Heroven et al, 2004, Cerdan et al., 2003,
Nye & Taylor, 2003, Navarre et al., 2006). It is interesting to note that foreign sequences
inherited by horizontal gene transfer are rich in adenine and thymine (AT-rich) compared
to that of their host. AT-rich sequences are more intrinsically curved (Zuber et al, 1994),
providing an explanation of how these regulatory circuits have evolved using H-NS, and
H-NS-like proteins as silencers of transcription (Lucchini et al, 2006, Oshima et al, 2006,
Navarre et al., 2006). Although this explains how foreign genes are selectively targeted
for silencing, the question still remains as to how H-NS silenced genes are to be
integrated into existing regulatory networks and expressed under appropriate conditions.

1.2 Transcriptional anti-silencing
Since transcriptional silencing, is a process that renders appreciable regions of DNA
inaccessible to proteins such as RNA polymerase (RNAP), DNA modifying enzymes,
etc., to which it would otherwise be able (Dorman et al., 1999, Yarmolinsky, 2000), the
mechanism that counters this makes previously inaccessible regions of DNA accessible
and has been coined anti-silencing. Anti-silencing differs from true activation in that
RNAP is not actively recruited to the DNA, with few exceptions e.g. ToxT of V. cholerae
(Nye et al, 2000). Anti-silencing can occur through a protein independent, or a protein
dependent mechanism and often a combination of the two is required for optimal
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performance. Therefore, in a protein dependent anti-silencing mechanism, the antisilencing protein can be any DNA binding protein that antagonizes, interferes with, or
alters, the action of a silencing protein, e.g. H-NS. Protein dependent anti-silencing
mechanisms generally occur in 3 ways (however, subtle variations in these themes exist,
and a anti-silencing proteins may function through more than one mechanism): through
direct competition with the silencing protein (this can include blocking the silencing
proteins polymerization), through altering the DNA in a way that transcription is allowed
to occur, and by de-stabilizing the repressive, silenced, DNA structure.
Protein independent anti-silencing
The simplest form of anti-silencing is a protein-independent mechanism which relies
on the static curvature of the DNA. The dimerization and bridging characteristic of HNS makes the protein uniquely sensitive to DNA structure. The static curvature of DNA
can facilitate H-NS cross-linking, but the curvature is also sensitive to environmental
conditions (De la Cruz et al, 2009, Falconi et al, 1998, Prosseda et al, 2004, Stoebel et al,
2008). Any condition that could alter the DNA structure would then antagonize the HNS induced bridging. Conditions that are known to alter the curvature of DNA are
temperature and osmolarity. An increase in temperature can reduce the degree of
curvature thereby reducing the ability of H-NS to constrain the bridged structure (Rohde
et al, 1999, Ussery et al, 1999), as observed in the case of the promoter of the virF
virulence gene in Shigella flexneri (Prosseda et al., 2004). Likewise a change in
osmolarity can also affect DNA curvature. The E. coli proU promoter, which is
negatively regulated by H-NS, is sensitive to changes in DNA superhelicity following
osmotic shock, which effects H-NS binding to its regulatory regions (Bouffartigues et al.,
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2007). Environmentally induced changes in DNA curvature might represent the most
fundamental mechanism of transcriptional anti-silencing, but more complex mechanisms
of anti-silencing exist in the literature.
Many horizontally acquired elements encode genes for protein antagonists of H-NS,
including Ler, Lrp, Fis, IHF, HU etc., and many of them share degenerate target
specificities, as H-NS does, making them ideal regulators involved in either, competition
for binding sites in DNA, or remodeling the architecture of the DNA that has a positive
effect on transcription (Dorman, 2004, Fang & Rimsky, 2008, Navarre et al, 2007,
Stoebel et al., 2008).
Protein dependent anti-silencing: direct competition
The protein dependent mechanism underlying transcriptional silencing/anti-silencing
has been proposed to be a straightforward molecular antagonism involving direct
competition between H-NS and other sequence specific DNA binding proteins for their
overlapping cognate DNA binding sequences (Fang & Rimsky, 2008, Navarre et al.,
2007). Examples of anti-silencing being a straightforward antagonism exist at a variety
of bacterial promoters, e.g. SlyA counters H-NS silencing of the hemolysin gene hlyE in
E. coli through direct competition, similarly RovA from Yersinia counters H-NS
silencing of the invasin inv, and the urease gene activator UreR of Proteus mirabilis
displaces H-NS by directly competing for essential binding sites (Coker et al, 2000,
Ellison & Miller, 2006a, Ellison & Miller, 2006b, Westermark et al, 2000, Heroven et al,
2004, Heroven et al, 2007, Lithgow et al, 2007, Poore & Mobley, 2003). The ToxT
transcription factor from Vibrio cholerae antagonizes H-NS at two promoters by direct
competition (Nye et al., 2000). In Salmonella, many of the genes regulated by SlyA are
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likely to have been acquired by horizontal gene transfer, and all but one of these is
repressed by H-NS (Navarre et al., 2005, Navarre et al., 2006). A mutual antagonism
exists between SlyA and H-NS where one protein is able to displace the other depending
on relative concentrations of the two proteins. This could represent one mechanism for
the re-establishment of H-NS mediated repression by allowing both proteins to utilize
similar mechanisms, allows fine-tuning of transcription in the cell (Lithgow et al., 2007).
This mechanism may be more common among silencing and anti-silencing proteins and
is unlikely restricted to SlyA and H-NS. Still another mechanism of counter-silencing by
direct competition has been observed where two proteins of E. coli, PapB and CRP,
appear to work in tandem to antagonize H-NS mediated silencing of the pap promoters
(Forsman et al, 1992).
Protein dependent anti-silencing: alteration of topology
In contrast, at some bacterial promoters the anti-silencing proteins function to alter
the DNA topology in a way that no longer allows H-NS to constrain transcription. For
example, LeuO counters silencing of the quiescent porin ompS1 in Salmonella by altering
the topology of the ompS1 promoter region (De la Cruz et al, 2007, De la Cruz et al,
2009) and in Shigella flexneri, VirB antagonizes H-NS by affecting the structure of the
icsB promoter (Turner & Dorman, 2007). The mechanism by which this is achieved
involves protein binding to specific binding sites followed by propagation of the protein
along the DNA with associated wrapping of the DNA. H-NS is no longer able to
maintain the repression complex, which allows RNAP to access the DNA and initiate
transcription (Beloin & Dorman, 2003, De la Cruz et al., 2009). Interestingly, the SlyA
protein of Salmonella, which directly competes with H-NS at the hlyE promoter,
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Fig. 4. Adapted from Stoebel et al., 2008. Illustration of the ways in which a repressive H-NS
promoter complex (a) can be modified to permit transcription. At certain promoters (b), specific
de-repression occurs via a protein-independent mechanism involving environmentally induced changes
in DNA bending or supercoiling (colored arrow). Many promoters are de-repressed via promoterspecific DNA-binding proteins (black arrows), which can work by preventing H-NS oligomerization
along the DNA (c), displacing H-NS, or modifying the conformation of the promoter, or both while
some H-NS remains bound (d), or displacing H-NS, by direct competition for H-NS binding regions
(e). Other de-repression mechanisms are general for many H-NS repressed promoters (grey arrows).
These include weakening the H-NS-promoter complex (H-NST)(f), or expression of an H-NS
paralogue (discussed in “silencing;” see above) that may enhance repression or alter its sensitivity to
other de-repression mechanisms dependent upon the exact properties of the protein-DNA complex (g).

functions to remodel the architecture of the DNA at the ugtL and pagC promoters (Kong
et al, 2008, Perez et al, 2008, Shi et al, 2004). LeuO has also been shown to block H-NS
propagation by binding between the H-NS upstream and downstream binding sites,
functioning as a boundary element (Chen & Wu, 2005, Chen et al, 2005). These results
show that a single H-NS antagonist can function via two distinct mechanisms: by direct
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competition, and remodeling the nucleoprotein complex (Stoebel et al., 2008). The
common feature that is shared by the H-NS antagonizing proteins is that most, if not all,
bind to AT-rich sequences, which may explain why these proteins have evolved to
function as anti-silencers (Navarre et al., 2006).
Protein dependent anti-silencing: destabilization
A third mechanism of counter-silencing, that is not often described, is the use of
truncated H-NS molecules (H-NST). The genes encoding these molecules have been
found in pathogenicity islands of pathogenic E. coli strains (Williamson & Free, 2005).
H-NST molecules show homology to the H-NS oligomerization domain, but lack nucleic
acid binding and linker regions (Willamson & Free, 2005). As opposed to the sequencespecific proteins directly competing with H-NS for binding to DNA, or remodeling the
nucleoprotein complex, H-NST molecules interfere with H-NS oligomerization and is
thought to weaken the ability of H-NS to form bridges by replacing full length H-NS.
However, the biologic significance of H-NST molecules remains unclear and examples
have not been demonstrated outside of the pathogenic E. coli strains (Navarre et al.,
2006, Stoebel et al., 2008, Williamson & Free, 2005).

1.3 Shigella, the bacterial pathogen
Shigella species are gram-negative intracellular pathogens that cause bacillary
dysentery in humans. Shigella infections are responsible for approximately 164 million
infections each year resulting in 1.1 million deaths, most of these occur in developing
countries and in children less than 5 years old (Kotloff et al, 1999, Lee et al, 2005, Li et
al, 2009). The genus is divided into 4 species, Shigella flexneri, Shigella boydii, Shigella
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sonnei, and Shigella dysenteriae. The species are further divided into serotypes based on
biochemical differences and variations in their O-antigens, such that, Shigella flexneri is
further divided into 13 serotypes. Shigella flexneri is endemic in most developing
countries and causes more mortality than any of the other Shigella species (Bennish &
Wojtyniak, 1991). Of the 13 serotypes of S. flexneri serotypes 1b, 2a, 3a, 4a, and 6 are
predominant in developing countries, while 2a is predominant in industrialized countries
including the United States (Kotloff et al., 1999).
Shigella pathogenicity
The mechanism of pathogenicity of Shigella flexneri is based on the capacity of the
organism, once ingested, to reach the colonic mucosa and to invade the colonic epithelial
cells. Invasion of the epithelial cells leads to intracellular bacterial multiplication, spread
to adjacent cells, cell death, and eventually inflammation and ulceration of the colonic
mucosa (Hale, 1991). This pathogenicity is a complex phenomenon, which relies on the
coordinated expression of a suite of genes, many of which are found on the large (230
kbp) virulence plasmid. The structural genes required for invasion, including a type III
secretion system (t3ss), and the intracellular spread of Shigella in host cells are encoded
by separate regions of the virulence plasmid: the ipa-mxi-spa locus and the icsA gene
(Dorman & Porter, 1998). The large virulence plasmid carries genes encoding key
virulence gene regulators. Further regulators of virulence gene expression in Shigella are
located on the chromosome: the plasmid-located positive transcriptional regulators virF
and virB and the chromosomally encoded negative regulator hns (Adler et al., 1989,
Dagberg & Uhlin, 1992).
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The regulatory cascade controlling Shigella virulence
The VirF and VirB proteins act in a cascade to activate virulence gene promoters in
response to environmental stimuli that indicate the bacterium is in the appropriate
location in the host. Temperature is a key regulatory factor of virulence gene
transcription, since virulence gene transcription is repressed at temperatures below 37 ℃.
H-NS has been shown to direct the temperature-regulated expression of virulence genes
by repressing their transcription during growth at 30 ℃ (Dorman et al., 1990, Hromockyj
et al., 1992). At the non-permissive temperature of 30 ℃, H-NS binds to two sites
within the virF promoter (Fig.5). The two regions of bound H-NS interact in the
formation of a nucleoprotein complex that results in repression of virF transcription. An
increase in temperature to 37°C, antagonizes the DNA topology resulting in the loss of
contact between the H-NS regions and this is thought to de-stabilize the nucleo-repressive
complex resulting in de-repression and subsequent transcription of the virF gene
(Falconi et al., 1998, Prosseda et al., 2004).

Fig. 5. From Dorman, 2004. H-NS mediated repression of the virF virulence-gene promoter
in Shigella flexneri. At the S. flexneri virF promoter, there are two binding sites for the H-NS
protein centered at -1 and -250 with respect to the transcriptional start site, which is shown with an
angled arrow. Formation of the repression complex at low temperatures requires looping of the
intervening DNA. The formation of a DNA topology that is conducive to repression is antagonized
by increased temperature. The resulting loss of contact between the bound H-NS proteins is
thought to result in the instability of the nucleoprotein complex at the virF promoter, leading to
derepression of transcription (Falconi et al., 1998)
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The major transcriptional activator VirF
Once expressed, VirF, an AraC-like transcription activator, binds directly to the virB
promoter. Tobe et al. (1995) have shown that VirF is present in vivo at both permissive
and non-permissive temperatures (although transcription of virF at 30 ℃ is one quarter
of that at 37 ℃ at which maximal transcription occurs) and that it can that it can bind in
vitro to the virB promoter at both temperatures. Therefore, the thermal activation signal
is not just production of VirF. These findings suggest that an increase in temperature
results in a change in DNA supercoiling that is responsible for the VirF dependent
activation of the virB promoter. Porter & Dorman (1997) also showed that virB DNA
topology was affected by changes in osmolarity and pH resulting in increased negative
supercoiling. Therefore, the alteration in DNA topology facilitates a productive
interaction between bound VirF and RNA polymerase and also raises the possibility that
a change in supercoiling may promote VirF oligomerization on the DNA, which results in
the antagonism of H-NS leading to transcription of virB (Fig. 5)(Dorman & Porter,
1998).

Fig. 6. The regulatory cascade controlling Shigella virulence. At the non-permissive temp of 30 ℃
H-NS causes repression of the major transcription factors virF and virB. Upon a shift in temperature to
the permissive temp of 37 ℃ a change in DNA topology relieves the H-NS induced repression of virF.
VirF antagonizes the H-NS induced repression of the virB promoter and subsequently VirB alleviates the
H-NS dependent repression of many virulence plasmid genes including those of the invasion locus; the
type III secretion system shown here is representative.
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Subsequently, VirB alleviates H-NS dependent repression of many virulence plasmid
genes, including those of the invasion locus ipa, mxi, and spa; virA, ospB and phoN2
(Beloin & Dorman, 2003, Berlutti et al, 1998, Maurelli et al, 1984a, Maurelli et al,
1984b, Maurelli & Sansonetti, 1988, Nicoletti et al, 2008, Prosseda et al, 1998, Sasakawa
et al, 1993, Tobe et al, 1991, Tobe et al, 1993, Tobe et al, 1995, Dorman, 2006,
Hromockyj et al., 1992, Porter & Dorman, 1994, Porter et al., 1998, Prosseda et al.,
1998).
The major transcriptional activator VirB: an unusual transcriptional regulator
The VirB protein
was first identified
through transposon
mutagenesis of the
large virulence
plasmid, when it was
shown to be essential
for the expression of
almost all the
structural virulence

Fig. 7. From Beloin et al.,2002. Model of VirBs functional
and structural domains. A structural model of VirB deduced
from experiments performed in Beloin et al., 2002. Below is the
structural model of the ParB protein based on the work of
Surtees & Funnell, 1999,2001. In ParB, DRS, represents
“discriminator recognition sequence,” implicated in the DNA
binding activity of ParB.

genes (Watanabe et al, 1990). VirB is an unusual candidate for a transcriptional activator
sharing no homology to previously described conventional transcriptional activators.
Instead, VirB shares considerable homology with a family of plasmid partition proteins,
including ParB and SopB, proteins that are involved in the plasmid partition and
maintenance of stable plasmid copy number in P1/P7 and F plasmids, respectively (Fig.
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7)(Watanabe et al., 1990, Abeles et al, 1985, Bignell & Thomas, 2001). VirB is small,
32 kDa, and basic and has been shown to form dimers, trimers, and higher order
oligomers in vitro and in vivo (Beloin et al, 2002). VirB can oligomerize independent of
DNA binding and occurs through two domains, a leucine zipper, and a C-terminal
domain predicted to form a triple coil structure (Beloin et al., 2002).
VirB shows homology to the partition proteins SopB/ParBVirB interacts with DNA in
vivo and is dependent on the presence of the N-terminus and the integrity of the helixturn-helix (HTH) binding motif. The HTH was found to be essential for structural gene
activation (Beloin et al., 2002). The HTH DNA-binding motif in VirB is 80% identical
to the HTH in the homologous ParB protein, which mediates the binding of ParB to parS
which leads to plasmid partitioning (Beloin et al., 2002, Lobocka & Yarmolinsky, 1996,
Surtees & Funnell, 2001).

Fig. 8. From Surtees & Funnell, 2001. The parS site. tall and short boxes outline the box A and box
B sequences respectively, and the black line shows the IHF binding site.

Beloin et al. (2002) showed that the leucine zipper (LZ) motif was essential for VirB
to form oligomers, and that oligomerization was essential for the VirB dependent
activation of a mxiC-lacZ fusion. Complete loss of the LZ resulted in complete loss of
the ability of VirB to activate gene expression and reduces its ability to bind DNA
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(Beloin et al., 2002). However, the LZ cannot promote protein:protein interactions in
isolation, instead it requires the C-terminal domain (Beloin et al., 2002). Therefore, the
LZ most likely functions to promote oligomerization, which is then stabilized by the Cterminal coiled-coil
structure, making both
regions mutually dependent
on one another
(Boss et al, 1999, Beloin et
Fig. 9. From Taniya et al., 2003. Comparison of the putative
InvE binding regions in S. sonnei. Beloin et al., (2002)
revealed that InvE (VirB) binds to the regions upstream of these
genes (icsB, spa-15, and virA) specifically. The numbers
indicate the positions of these regions (translation start site of
each gene as nucleotide +1). The boxes indicate the position of
the ParB BoxA-like sequence. The solid arrows indicate the
direction of each gene transcription.

al., 2002). Also, the HTH
motif was found to be
essential in DNA binding
but did not contribute

significantly to VirB oligomerization (Beloin et al., 2002, (McKenna et al, 2003). The
work of Beloin et al.(2002), and later McKenna et al. (2003), demonstrated that VirB is a
direct DNA binding protein that interacted specifically with the promoters of the
virulence genes its known to regulate. They also demonstrated the necessity of VirB
oligomerization in the activation of the structural genes, a situation that resembles the
homologous ParB and SopB functions (Beloin et al., 2002, McKenna et al., 2003). ParB
oligomerization, which ultimately leads to protein:DNA bridges via protein:DNA and
protein:protein interactions, is an essential step in the formation of the partition complex
to effectively segregate plasmids (Bouet et al, 2000, Schumacher & Funnell, 2005,
Schumacher et al, 2007). Even though VirB shows homology to ParB and SopB there is
no data to support that VirB is involved in plasmid partitioning or maintenance of the
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modern virulence plasmid (McKenna et al., 2003, Harrison et al., unpub. data). While
there is structural homology between VirB and ParB/SopB, there are functional
differences. Firstly, ParB represses transcription (by spreading along the DNA for great
distances eg. 2 kb)(Lobocka & Yarmolinsky, 1996, Rodionov et al., 1999), while VirB
activates transcription by alleviating transcriptional repression (Beloin et al., 2002).
Secondly, ParB binds to a well defined parS site of plasmid P1 (Fig. 8) which consists of
4 box A sequences (heptameric) and 2 box B sequences (hexameric) imperfect repeats,
separated by an integration host factor (IHF) binding site (Surtees & Funnell, 2001), in
contrast VirB binds to a sequence that is homologous to the box A motif in the parS site,
and this site in the S. sonnei icsB promoter is essential for the expression of the ipa
operon. Based on a previous study in S. flexneri (Beloin et al., 2002) which showed VirB
(InvE) binding to various promoter sequences, Taniya et al. (2003) also found this 7 bp
ParB box A-like sequence [5’-(A/G)(A/T)G(G)AAAT-3’] in 2 additional promoter
sequences (Fig. 9). In fact this sequence was shown by gel shift assay to be required for
InvE binding (Taniya, et al., 2003). This work was further corroborated by Turner &
Dorman (2007) which showed that VirB bound to a regulatory region within the
divergently transcribed S. flexneri icsB-ipgD promoter that contained a near-perfect,
inverted repeat, which is homologous to the parS box A sequence (labeled box 1 and box
2) (Fig. 10). However, in Turner & Dorman (2007), only the promoter distal binding site
(box 2) was found to be critical for the VirB-mediated activation of the promoter.
Interestingly, the icsB regulatory region shows DNA sequence homology to the parS site
of plasmid P1 and P7, and furthermore, icsB shares a dependency, as does parS, on the
IHF protein (IHF has been shown to bind and enhance activity of the icsB promoter; IHF
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Fig. 10. From Turner & Dorman, 2007. Comparison of icsB and parS. A) alignment of the icsB
regulatory region with the parS sequences of phages/plasmids P1 and P7. The DNA sequence of the
promoter-distal portion of the icsB regulatory region that contains boxes 1 and 2 is aligned with the
parS sequences of phages/plasmids P1 and P7. The converging horizontal arrows show the inverted
repeats associated with boxes 1 and 2. The four heptameric and two hexameric parS motifs involved
in ParB protein interaction are boxed by solid- and dotted-line rectangles, respectively. Downwardpointing arrowheads indicate residues within the hexamers that allow ParB proteins to distinguish
different parS sequences. The asterisks indicate residues that are conserved between the icsB
regulatory region and the parS sequences. B) Genetic map of the portion of the large virulence
plasmid showing the relative locations of the virB gene and the regulatory sequences of the icsB-ipgipa-acp operon. The angled arrows represent promoters. The relative positions of the box 1 and box
2 motifs upstream of the icsB promoter are shown. The diagram is not drawn to scale.

is required for full activation of virF and virB) (Turner & Dorman, 2007, Porter &
Dorman, 1997). Together, these findings suggest that VirB is likely to be specific for the
promoters that contain this box 2 element, or at least close matches to it. The
significance of this finding suggests that VirB is a former plasmid partitioning protein
that has been conscripted to perform a new function, that of an anti-silencer, antagonizing
the H-NS mediated repression of promoters (Turner & Dorman, 2007). Unlike the
ParB/parS system, the virulence plasmid of Shigella does not encode for a partner protein
for VirB that is equivalent to ParA. The ParA protein is an accessory ATPase that
interacts directly with ParB bound at parS and is required for the proper localization of
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the ParB-parS complexes, although it is not known how this positioning is accomplished
(Bouet & Funnell, 1999). Although, it is possible that another protein interacts with
VirB, by binding the N-terminal domain of VirB, as proposed in the work of Beloin et al.
(2002) to date no such co-factor has been found. Future investigations may one day find
an accessory protein for VirB.
VirB function
The mechanism by which VirB activates transcription is not completely understood.
At the icsB promoter, VirB has been reported to bind and oligomerize on DNA to a short
sequence [5’-(A/G)(A/T)G(G)AAAT-3’] located upstream of the promoter, and this
binding is required for activity of this promoter (Beloin et al., 2002, McKenna et al.,
2003, Taniya et al., 2003). However, this sequences occurs 56 times on pWR100 of
Shigella flexneri, including within numerous insertion sequences scattered along the
plasmid, and many more (more than 1000 times) with one mismatch, suggesting that this
sequence alone does not define the VirB target (Le Gall et al, 2005). An examination of
all the genes under the control of VirB show a lower G+C content, compared to the host,
therefore, bending might be an essential part of the VirB recognition motif (it should be
noted that not all promoters with low G+C content are under the control of VirB) (Le
Gall et al., 2005). It has been shown that the promoters under the positive transcriptional
control of VirB are also under the negative transcriptional control of H-NS, and that VirB
has been shown to displace H-NS from these promoters (Turner & Dorman, 2007, Beloin
et al., 2003). This further strengthens the case for curvature of DNA playing an
important role in the VirB dependent activation of the promoters for which it regulates.
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These studies, and many more, all point to a finely tuned mechanism of regulation
involving the H-NS mediated repression of the virulence system in S. flexneri, that would
not be permitted to be expressed until the appropriate environmental signals initiate a
regulatory cascade involving VirF and VirB, that would limit the wasteful expression of
the type III secretion system, its effector proteins and additional factors until authentic
contact with host. However, many more questions remain to be answered, e.g.; What are
the full repertoire of genes under the control of VirB? How does VirB alleviate H-NS
mediated repression of promoters? Does VirB have more than one mechanism, which
can be employed to alleviate H-NS repression? Is there a better-defined VirB binding
motif? An enhanced understanding of the silencing/anti-silencing mechanisms that
control expression of virulence genes in Shigella, and many other bacteria, is central to
understanding pathogenesis.

1.4 Objectives of this study
The aim of this work is to determine the role that H-NS and VirB play in the
regulation of the icsP promoter and to examine the molecular mechanism of silencing
and anti-silencing. This dissertation is divided into three main chapters encompassing
five objectives.

Objective 1: To determine regions of the icsP promoter needed for H-NS induced
repression and regions required for VirB dependent de-repression. This objective is
addressed in chapters 2 and 3.
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Objective 2: To demonstrate H-NS and VirB bind directly to the icsP promoter.
This objective is addressed in chapters 3 and 4.
Objective 3: To determine the sequences to which H-NS and VirB bind. This
objective is addressed in chapters 3 and 4.

Objective 4: To examine the effect that icsP static DNA curvature plays in the ability
of H-NS and VirB to regulate promoter activity. This objective is addressed in
addressed in chapter 4.

Objective 5: To propose a mechanism for the H-NS and VirB regulation of the icsP
promoter. This objective is addressed in all chapters and model is presented in
chapter 5.
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CHAPTER 2
VIRB ALLEVIATES H-NS REPRESSION OF THE ICSP PROMOTER IN SHIGELLA
FLEXNERI FROM SITES OVER 1 KB UPSTREAM OF THE TRANSCRIPTION
START SITE
Abstract
The icsP promoter of Shigella spp. is repressed by H-NS and derepressed by the VirB.
An inverted repeat located between -1144 and -1130 relative to the transcription start is
required for VirB dependent de-repression of the icsP promoter. The atypical location of
this cis-acting site relative to the promoter is discussed.
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2.1 Introduction
Shigella species are gram-negative intracellular pathogens that invade cells of the
lower intestinal epithelia of humans and primates, causing bacillary dysentery. All
Shigella species carry a large virulence plasmid, and many genes carried by these
plasmids are thermo-regulated. At a non-permissive temperature of 30°C, the global
regulator H-NS (histone-like nucleoid structuring protein) represses transcription of
many virulence plasmid genes (Beloin & Dorman, 2003, Porter & Dorman, 1994,
Hromockyj et al, 1992). At the permissive temperature of 37°C, H-NS dependent
repression is relieved by temperature induced changes in DNA topology (Falconi et al.,
1998, Prosseda et al., 1998), VirF, or its subordinate regulator VirB (InvE) (reviewed in
reference Porter & Dorman, 1997). The mechanism that leads to the alleviation of
transcriptional repression by H-NS has been coined “anti-silencing.” Anti-silencing is
thought top play an important role in controlling the expression of genes acquired
through horizontal gene transfer and is common in bacterial pathogens in which a
variety of transcription factors function to relieve repression by H-NS (reviewed in
reference Stoebel et al., 2008).
The icsP (sopA) gene is carried on the large virulence plasmid in all Shigella species
(Egile et al, 1997, Shere et al., 1997) and encodes an outer membrane protease, which
belongs to the omptin protease family (Hritonenko & Stathopoulous, 2007, Kukkonen &
Korhonen, 2004) and cleaves the actin-tail assembly protein IcsA from the surface of
Shigella (Egile et al, 1999, Shere et al., 1997, Steinhauer et al., 1999). Previous studies
have revealed that icsP, like other Shigella virulence plasmid genes, including virA,
ospB and phoN2 and those of the invasion locus ipa, mxi, and spa (Adler et al, 1989,
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Berlutti et al, 1998, Beloin et al., 2002, Sakai et al., 1988, Santapaola et al., 2006,
Taniya et al., 2003, Tobe et al., 1991, Uchiya et al., 1995) is repressed by H-NS and derepressed by VirB (Wing et al., 2004). In this study, we identify sequences upstream of
the icsP gene necessary for de-repression by VirB, with a view to improve our
understanding of the mechanism of transcriptional anti-silencing at the icsP promoter.
2.2 Materials and Methods
Bacterial strains, plasmids and media.
The bacterial strains and plasmids used in the present study are listed in Appendix 1.
Bacteria were grown routinely at 37°C in Luria-Bertani (LB) broth with aeration or on
LB agar (LB broth containing 1.5% [wt/vol] agar). Antibiotics, as needed, were added to
achieve the following final concentrations: ampicillin, 100 µg/ml; chloramphenicol, 25
µg/ml; kanamycin, 50 µg/ml; and tetracycline, 12.5 µg/ml. Where appropriate, to ensure
that Shigella strains had maintained the large virulence plasmid during manipulation,
Congo Red binding was tested on Trypticase Soy Agar (TSA) plates containing 0.01%
(wt/vol) Congo Red (Sigma Chemical Co., St. Louis, Mo.).
Construction of the PicsP-lacZ reporter plasmid and truncated promoter fragments.
The starting point for this work was the PicsP-lacZ reporter plasmid pHJW7
(described in Wing et al, 2004; Table 1). pHJW7 carries a PstI XbaI DNA fragment that
contains 1232 bp upstream of the transcription start site of the icsP promoter and the first
48 bp of the icsP coding region. This fragment is cloned upstream of a translation stop
site and a promoterless lacZ gene, so that expression of lacZ is directly regulated by the
icsP promoter. To facilitate the construction of a series of PicsP-lacZ fusion plasmids, a
second XbaI restriction site located downstream of the lacZ gene in pHJW7 was removed
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using the ‘mega’-primer PCR method (Perrin & Gilliland, 1990) with oligonucleotides
W1016-1018 (Appendix 1). The resulting plasmid, pHJW20 (Table 1), contains a unique
XbaI site upstream of the lacZ gene. icsP promoter fragments were PCR amplified from
pHJW20 using oligonucleotide W89 in combination with each of the following
oligonucleotides: W44, 45, 46, 47, 528, 529 or 530 (Appendix 1). PCR products were
digested with PstI and XbaI, and were ligated into pHJW20 that had also been digested
with PstI and XbaI. This created a series of PicsP-lacZ fusion plasmids containing
promoter fragments lengths of 1056 bp, 893 bp, 665 bp, 351 bp, 254 bp, 150 bp, and 92
bp, respectively. These plasmids were called pJS01, pJS02, pDH01, pJS04, pHJW34,
pHJW35 and pHJW36, respectively (Appendix 1).
To create pMIC01, pHJW20 was digested with SalI and PstI, treated with T4 DNA
polymerase and self-ligated using the blunt-ended ligation protocol supplied with T4
DNA ligase (Promega). To create pMIC02, a 200 bp fragment was amplified by PCR
from the virulence plasmid of the S. flexneri strain 2457T using oligonucleotides W81
and W82 (Appendix 1). The product was digested with SalI and PstI and the resulting
fragment was ligated with pHJW20 that had also been digested with SalI and PstI. This
created a PicsP-lacZ fusion carrying 1473 bp of sequence naturally found upstream of the
icsP transcription start site. The promoterless reporter plasmid pMIC21 was created by
removing the entire icsP promoter from pHJW20. To do this, pHJW20 was digested with
PstI and XbaI, the resulting DNA was treated with T4 DNA polymerase and self-ligated
using the blunt-ended ligation protocol supplied with T4 DNA ligase (Promega). The
sequence of all truncated promoters fragments was confirmed after cloning. All plasmids
are described in Appendix 1.
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In silico analyses of the icsP promoter and upstream sequences.
Curvature predictions of the icsP promoter and upstream sequences were performed
using the bend.it® program (http://www.icgeb.org/dna/bend_it.html. The curvature is
calculated as a vector sum of dinucleotide geometries (roll, tilt and twist angles) using the
BEND algorithm (Goodsell & Dickerson, 1994) and expressed as degrees per helical turn
(10.5°/helical turn = 1°/bp). Experimentally tested curved motifs produce curvature
values of 5–25°/helical turn, whereas straight motifs give values below 5°/helical turn.
To analyze sequences upstream of the icsP tss, the program “Clone Manager 9, Basic
Edition” (Scientific and Educational Software) was used. Open reading frames (ORFs)
greater than 50 amino acids were identified using the “ORF search” feature and the
“Open Reading Frame analysis” feature was used to predict whether ORFs were coding
regions. The “Open Reading Frame analysis” feature uses Fickett's TESTCODE
algorithm (Fickett, 1982) to generate a score that can help to determine whether or not
an ORF is likely to be a protein coding region and is based on the observed asymmetry
of base utilization within coding regions. ORFs with scores over 0.95 are predicted to
be coding regions. To predict whether predicted coding regions identified by our search
were linked to possible promoter sequences, the BPROM program (Softberry) was used.
This algorithm predicts potential transcription start positions of bacterial genes regulated
by sigma70 promoters (major E. coli promoter class). Linear discriminant function
combines characteristics describing functional motifs and oligonucleotide composition
of these sites. BPROM has an accuracy of E. coli promoter recognition of about 80%.
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Site-directed mutagenesis of upstream putative VirB-binding sites.
The two upstream putative VirB-binding sites were mutated using site-directed
mutagenesis by PCR using a two step procedure, as described previously (Lie & Leigh,
2007) using primers listed in Table 2. In the first step, the 5’ binding site and the 3’
binding site were amplified in two separate PCRs. To amplify the 5’ binding site, a
reverse oligonucleotide, either mutagenic (W100) or complementary to the wild-type
sequence of the putative VirB-binding site (W99), was used with a forward primer
(W98). To amplify the 3’ binding site a forward primer, either mutagenic (W110) or
complementary to the natural sequence of the putative VirB-binding site (W101), was
used with a reverse primer (W89). These reactions created four products: a 5’ binding
site with wild-type sequence; a mutated 5’ binding site; a 3’ binding site with wild-type
sequence and a 3’ mutated binding site. All PCR products were gel purified and treated
with Promega T4 DNA polymerase (as per manufacturer’s instructions) to remove 3’
overhanging nucleotides. In the second stage of the procedure, the PCR products were
ligated together in three different combinations using Promega T4 DNA ligase (as per
manufacturer’s instructions): wild-type 5’ sequences were ligated to mutagenic 3’
sequences, mutated 5’ sequences were ligated to wild-type 3’ sequences, and mutated 5’
sequences were ligated to mutated 3’ sequences. Where necessary, 5' phosphates were
incorporated during oligonucleotide synthesis (Appendix 1). The resulting ligations
were used as template in a second round of PCR using oligonucleotides W89 and W98.
This PCR allowed the amplification of correctly oriented promoter fragments. Correctly
sized PCR products were then gel purified and digested with PstI and BglII. The
resulting DNA fragments were cloned into a pHJW20 PstI BglII vector to give pMIC13,
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pMIC17 and pMIC18. The sequence of all mutated promoters fragments was confirmed
after cloning.
Quantification of icsP promoter activity using the PicsP-lacZ reporter and
derivatives.
To measure promoter activities the PicsP-lacZ fusion plasmids described in this work
were introduced into S. flexneri and E. coli strains by electroporation. Activities of the
icsP promoter constructs were determined by measuring β-galactosidase activity as
described previously (Wing et al, 2004), using the Miller protocol (Miller, 1972).
Overnight cultures were diluted 1:100 and grown for 4 to 5 h in either TSB medium (S.
flexneri) or LB (E. coli) at 37°C, prior to cell lysis. Routinely, β-galactosidase levels
were measured in early stationary phase cultures grown from three independent
transformants because experiments had shown that icsP expression significantly
increases under these conditions (data not shown).
2.3 Results and Discussion
Identification of sequences required for VirB dependent regulation of icsP
promoter
Previous work has demonstrated that VirB regulates an PicsP-lacZ fusion integrated
into the icsP locus on the Shigella virulence plasmid (Wing et al., 2004). To identify
regions upstream of the icsP gene that mediate VirB dependent de-repression, a nested
set of promoter deletions was created (Fig. 2A) and cloned into a medium-copy-number
lacZ reporter pHJW20 (Appendix 1) to replace the existing 1,232 bp icsP promoter
fragment. This created a set of eight PicsP-lacZ fusions whose upstream limits varied
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from -1232 to -92 relative to the previously annotated transcription start site of the icsP
gene (Egile et al, 1997) (Fig. 11A; Appendix 1).

Fig. 11. Promoter elements of the icsP promoter and schematic representation of the truncated
promoter series. (A) Angled arrows represent the icsP transcriptional start site (+1), determined
previously (Egile et al., 1997). The -10 and -35 hexamers are boxed and shown in bold. The
translational start site is represented by an open arrow. The truncated promoters are drawn to scale
and numbers represent the upstream boundary of the icsP promoter, relative to the tss (+1). The
promoter fragments represented are found in pHJW20, pJS01, pJS02, pDH01, pJS03, pHJW34,
pHJW35 and pHJW36, respectively. (B) Solid black arrows represent the relative position and
orientation of the nine putative VirB binding sites identified within the promoter fragments used in
this work. In each case, the match to the consensus sequence 5’-(A/G)(A/T)G(G)AAAT-3’ (Tobe et
al., 1993, Watanabe et al., 1990) is given.

Each promoter construct was introduced into wild-type Shigella 2457T and a mutant
derivative, AWY3 (virB::Tn5), and β-galactosidase production was measured using the
Miller protocol (Miller, 1972). Of the eight promoter fragments tested, only one
displayed a >2-fold increase in the presence of VirB (Fig. 12). Surprisingly, this was the
longest promoter fragment (found in pHJW20). The activity of this promoter fragment
was 17-fold higher in the presence of VirB than its absence. This increase was unlikely
to be caused by sequences in the pACYC184 plasmid backbone, because these
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sequences would also influence the activity of the other promoter fragments.
Furthermore, the increase in promoter activity was unlikely to be caused by the creation
of a new VirB binding site at the boundary of the plasmid backbone and the promoter
region, because two additional constructs with altered plasmid-promoter boundaries
(pMIC01 and pMIC02 [Table 1]) were found to have similar activities to those displayed
by pHJW20.
The simplest interpretation of these data was that DNA sequences located between
positions 1232 and 1056 upstream of the icsP transcription start site are required for
VirB dependent regulation of the icsP promoter.

Fig. 12. Activities of the truncated icsP promoter series in Shigella. Bars indicate βgalactosidase expression of the PicsP-lacZ fusions in wild-type S. flexneri (2457T) and an isogenic
strain lacking virB (AWY3). β-galactosidase activities are expressed in Miller units. Assays were
run in triplicate and the mean and standard deviations are shown.
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Identification and site-directed mutagenesis of putative VirB binding sites
responsible for VirB-dependent regulation of the icsP promoter.
Previous analysis of the icsB, spa15 and virA promoters of Shigella sonnei
established a consensus binding site for VirB (Taniya et al, 2003). Our analysis of
sequences upstream of the icsP gene identified nine sites with greater than a 6/7 match
to the consensus, 5’-(A/G)(A/T)G(G)AAAT-3’ (Fig. 12B; Turner & Dorman, 2007).
Three of these sites are located between -665 to -351. The location of these sites may
explain why small and yet significant increases in VirB dependent promoter activity
were observed in wild-type Shigella flexneri carrying promoter constructs with upstream
boundaries of -665, -883 and -1056 relative to the icsP transcription start site (+1) (Fig.
11). Two other putative VirB binding sites are located immediately downstream of the
transcription start site. Although the location of these sites may explain the small
increase in VirB dependent promoter activity associated with the shortest promoter
fragment used in our studies, our data suggest that these sites alone play no significant
role in the presence of upstream promoter sequences.
Interestingly, two of the nine sites identified upstream of the icsP gene are located
between positions -1144 and -1130 and are organized as an inverted repeat (Fig. 11B).
Since our truncation analysis indicates that sequences between -1232 and -1063 are
essential for a 17-fold increase in promoter activity in the presence of VirB (Fig. 12), we
chose to analyze these sites further. Seven base pair substitutions were made in either,
the upstream site (box 2), the downstream site (box 1) or both, using a PCR sitedirected mutagenesis method described by Lie & Leigh (2007) (Appendix 1; Table 1).
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Table 1. Summary of mutations introduced into the two boxes that form the upstream

inverted repeat and activities of wild-type and mutated icsP promoter fragments
Fragment description

WT Box 1 & 2
Mutated Box 1
Mutated Box 2
Mutated Box 1 & 2

Sequencea

CGGGGATTTCAGTATGAAATGAAGTA
CGGGGATTTCAGTCGACCCGGAAGTA
CGGGGGCCCAGCTATGAAATGAAGTA
CGGGGGCCCAGCTCGACCCGGAAGTA

β-galactosidase activity b
virB+

virB mutant

4291 ± 453

397 ± 12

345 ± 46

378 ± 29

370 ± 65

359 ± 29

360 ± 57

371 ± 26

346 ± 70
415 ± 33
Promoterless lacZ
5’-3’ DNA sequences of the wild-type and mutated boxes that form the upstream inverted repeat.
Sequences lie between -1144 and -1130 relative to the annotated tss of icsP (+1;(Egile et al., 1997)).
Bases in bold indicate those mutated by site-directed mutagenesis.
b
All promoter fragments were fused to lacZ and β-galactosidase activities were measured in wild-type S.
flexneri (2457T) and the isogenic strain that lacks virB (AWY3). The parent cloning vector with a
promoterless lacZ gene was included as a negative control. β-galactosidase activities are expressed in
Miller units. Assays were run in triplicate and the mean and standard deviations are shown.
a

Each mutated promoter fragment was then introduced into the lacZ reporter plasmid
pHJW20 to replace the existing wild-type sites the resulting plasmids pMIC13, pMIC17,
pMIC18, and pHJW20 and a promoterless control, pMIC21 (Table 1) were introduced
into wild-type Shigella (2457T) and the virB mutant (AWY3) and β-galactosidase levels
were measured (Table 1).
Our data revealed that complete mutagenesis of the upstream binding site (box 2), the
downstream binding site (box 1) or both, resulted in complete loss of VirB dependent
regulation of the icsP promoter. Further more, these results were not an artifact of the
lacZ reporter constructs, because similar patterns of expression were observed when the
icsP gene was fused to each of our promoter constructs and IcsP levels were measured
by Western blotting (data not shown). These data strongly suggest that VirB regulates
the icsP promoter from sequences located more than 1 kb upstream of the icsP
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transcription start site. To our knowledge, this is the first evidence that VirB can
influence promoter activity from such distal sites.
Conserved sequence and location of the two distal VirB binding sites in all known
Shigella sequences and in EIEC strain HN280.
To examine how well conserved DNA sequences located upstream of the icsP
promoter are among other Shigella strains, species and other enterics, a 2 kb sequence
upstream of the icsP gene in Shigella flexneri 2457T was subjected to BLAST analysis.
All known Shigella virulence plasmid sequences and the virulence plasmid of the
enteroinvasive Escherichia coli (EIEC) strain HN280 contain nearly identical sequences
(99-100% identity) over the entire 2 kb sequence upstream of the icsP gene.
Furthermore, the upstream inverted repeat identified by our studies was 100% identical in
all strains and located in exactly the same position relative to the annotated transcription
start site identified in S. flexneri. These findings strongly suggest that icsP genes found
in all Shigella spp. and the EIEC strain HN280 are likely to be regulated by VirB from a
biding site located more than 1 kb upstream of the gene.
VirB is structurally homologous to plasmid partitioning proteins, which can
influence transcription from distances of several kilobases.
While it is unusual for transcription factors to influence transcription from
distances greater than 200 bp upstream or downstream of the transcription start site in
bacteria (Balleza et al., 2009, Collado-Vides et al, 1991), some examples exist. For
example, the enhancer of the Bacillus subtilis rocG gene is located 1.5 kb downstream
of the promoter and, beyond the end of the rocG coding region (Belitsky et al., 1999)
and the two NtrC binding sites required for transcriptional activation of E. coli σ54-
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regulated glnA promoter can still function when placed as far as 3 kb from the promoter
(Reitzer & Magasanik, 1986). Furthermore, bacterial plasmid partitioning factors, while
not typically considered transcription factors, have also been shown to silence the
promoters of genes in the vicinity of their cis-acting binding sites from over distances of
several kilobase pairs (Kim & Wang, 1999, Rine, 1999, Rodionov et al, 1999, Rodionov
& Yarmolinsky, 2004). One of these proteins, the P1 ParB protein, displays structural
homology to VirB and has bridging capabilities: the ability to interact with other ParB
monomers located at binding sites further up or downstream. It is therefore possible that
the other seven sites with close matches to the VirB consensus binding site play an
important role in bridging by VirB and the resulting DNA topology is central to the
alleviation of H-NS dependent repression of the icsP promoter, although this needs to be
tested.
In summary, although transcription factors typically bind to sequences located
within 200 bp upstream or downstream of the transcription start site (Balleza et al, 2009,
Collado-Vides et al, 1991), here we provide strong evidence that VirB has the capacity
to alleviate H-NS dependent repression of the icsP promoter from sites located over 1 kb
upstream of the transcription start site. This raises two important questions. (i) Are
other Shigella virulence plasmid genes regulated from remote VirB binding sites? (ii) Is
it common for transcriptional anti-silencing mechanisms to employ distal regulator
binding sites? Future studies will address these questions and elucidate the molecular
mechanism of H-NS dependent repression and VirB dependent de-repression of the icsP
promoter.
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CHAPTER 3
TRANSCRIPTIONAL SILENCING AND ANTI-SILENCING OF THE ICSP
PROMOTER OF SHIGELLA FLEXNERI: REMOTE REGULATION
BY H-NS AND VIRB
Abstract
In the bacterial pathogen Shigella flexneri, many genes encoded by the large
virulence plasmid are repressed by the nucleoid structuring protein H-NS and derepressed by the major virulence gene activator VirB. One example is the icsP gene,
which encodes an outer membrane protease. In this study, we demonstrate that
sequences located over 665 bp upstream of the annotated transcription start site (+1) are
needed for complete H-NS-mediated repression of the icsP promoter. Using
electrophoretic mobility shift assays (EMSAs), we show that H-NS binds directly to
DNA sequences located both upstream of -665 and downstream of -213 and that both of
these regions contain sequences predicted to display high levels of intrinsic curvature.
These data support a model where H-NS docked at remote sites may act in concert with
H-NS docked at promoter proximal sequences to mediate H-NS-dependent repression of
the icsP promoter. While we again demonstrate that VirB functions solely to de-repress
the promoter, our EMSA data indicate that VirB and H-NS are capable of binding
simultaneously to the full intergenic region (1232 bp) that lies immediately upstream of
the icsP gene. This suggests that VirB may function to relocate H-NS, rather than
causing H-NS to dissociate from the DNA upstream of the icsP gene. Our findings
contribute to our understanding of transcriptional silencing and anti-silencing
mechanisms that control virulence gene expression in Shigella and other enteric
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pathogens and raise the possibility that other bacterial promoters may be regulated from
remote transcription factor binding sites.
Authors: Dustin J. Harrison, Karen M. Levy, Amber J. Howerton, Christopher T.
Hensley and Helen J. Wing
We thank Dr. Eric Anderson and Dr. Martin Roop from East Carolina University for
all their help and guidance with the EMSAs, Stephanie Labahn for technical support and
Drs. Eduardo Robleto, Dennis Bazylinski and Patricia Cruz for critical reading of the
manuscript.
3.1 Introduction
Shigella species are gram-negative intracellular pathogens that cause bacillary
dysentery in humans. Shigella infections are responsible for approximately 164 million
infections each year resulting in 1.1 million deaths, most of these occur in developing
countries and in children less than 5 years old (Kotloff et al., 1999, Lee et al., 2005, Li et
al., 2009). All four Shigella species carry a large (230 kbp) virulence plasmid. Many
genes encoded by these plasmids are under the transcriptional control of the histone-like
nucleoid structuring protein (H-NS) and the major virulence gene activator VirB (Adler
et al., 1989, Berlutti et al., 1998).
H-NS is a nucleoid structuring protein that is well characterized as a silencer of
bacterial transcription (Ali Azam et al., 1999, Dorman, 2004). In enteric pathogens, HNS silences the transcription of many virulence genes, which have been acquired by
horizontal gene transfer (Dorman, 2009a). Silencing of newly acquired genes by H-NS is
thought to protect the bacterium from potentially deleterious effects of transcribing genes
that may compromise their fitness (Navarre et al., 2006) until they can be integrated into
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existing regulatory networks (Navarre et al., 2007, Dorman, 2009b). Among the enterics,
horizontally acquired genes are frequently AT rich. Such sequences typically display high
levels of intrinsic curvature. Previous investigations indicated that H-NS is a direct, nonspecific DNA binding protein with an affinity for DNA with high intrinsic curvature
(Spassky et al., 1984, Zhang et al., 1996, Zuber et al., 1994, Williams et al., 1996,
Williams & Rimsky, 1997, Yamada et al., 1991, Zuber et al., 1994) which may explain,
at least in part, why H-NS is the protein of choice for transcriptional silencing in these
bacteria. More recent work at the E. coli proU promoter (Lang et al., 2007) has led to the
description of a high affinity H-NS binding site, however it remains unclear whether this
sequence is found in all H-NS regulated promoters, or whether other sequences can
contribute to H-NS binding. Regardless, DNase I protection assays have demonstrated
that H-NS oligomerizes along AT rich sections of bacterial promoters (Rimsky et al.,
2001, Turner & Dorman, 2007). This can lead to the formation of H-NS-DNA-H-NS
bridges, which have been visualized using atomic force microscopy as looped DNA
structures constrained by H-NS (Maurer et al., 2009). These structures may involve long
stretches of DNA, extending over 1 kb (Dame et al., 2000, Dame et al., 2005, Dame et
al., 2006, Maurer et al., 2009), and have been documented as playing important roles in
promoter silencing (Bouffartigues et al., 2007, De la Cruz et al., 2009, Dorman, 2004,
Dorman, 2009a, Fang & Rimsky, 2008, Navarre et al., 2006, Stoebel et al., 2008).
Disruption of these H-NS:DNA complexes by other DNA-binding proteins can allow
transcriptional de-repression; a process coined anti-silencing (Fang & Rimsky, 2008,
Navarre et al., 2007, Stoebel et al., 2008).
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The virulence gene activator VirB is encoded by the Shigella virulence plasmid and
its expression is regulated by another transcription factor VirF (Adler et al., 1989). At
the non-permissive temperature of 30 ˚C many genes encoded by the virulence plasmid
are repressed by H-NS (Beloin & Dorman, 2003, Hromockyj et al., 1992, Porter &
Dorman, 1994). Upon a switch to 37 °C, H-NS dissociates from the virF promoter
leading to the production of the virulence gene regulator, VirF (Adler et al., 1989). VirF
relieves H-NS-dependent repression of the virB promoter (Tobe et al., 1993, Watanabe et
al., 1990) and subsequently VirB alleviates H-NS dependent repression of many
virulence plasmid genes, including virA, icsP, ospB, phoN2 and those encoding the type
III secretion system that mediate host cell invasion; ipa, mxi and spa (Beloin & Dorman,
2003, Berlutti et al., 1998, Dorman, 2006, Hromockyj et al., 1992, Maurelli et al., 1984a,
Maurelli et al., 1984b, Nicoletti et al., 2008, Porter & Dorman, 1994, Porter et al., 1998,
Prosseda et al., 1998, Sasakawa et al., 1993, Tobe et al., 1991, Tobe et al., 1993, Tobe et
al., 1995). Consequently, transcriptional de-repression of virulence genes by VirF and
VirB is central to the pathogenicity of Shigella. Since VirF and VirB both function to
antagonize H-NS mediated repression of virulence genes, both proteins can be considered
transcriptional anti-silencing proteins.
The mechanism underlying transcriptional silencing/anti-silencing has been proposed
to be a straightforward molecular antagonism involving competition between the
silencing protein and the anti-silencing protein for their overlapping cognate DNA
binding sequences, which are usually located in the immediate vicinity of the promoter.
Typically this competition results in the dissociation of the silencing molecule from the
DNA (Fang & Rimsky, 2008, Navarre et al., 2007). Examples of this kind of
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straightforward transcriptional silencing/anti-silencing exist at a variety of bacterial
promoters, e.g. SlyA counters H-NS silencing of the hemolysin gene hlyE in E. coli
through direct competition for the DNA, RovA from Yersinia counters silencing of the
invasin inv, and the urease gene activator UreR of Proteus mirabilis causes H-NS to
dissociate from DNA located between the divergently transcribed ureR and ureD genes
(Coker et al., 2000, Ellison & Miller, 2006a, Ellison & Miller, 2006b, Heroven et al.,
2004, Heroven et al., 2007, Lithgow et al., 2007, Poore & Mobley, 2003). In contrast, at
some bacterial promoters the anti-silencing proteins function to alter the DNA topology
in a way that no longer allows H-NS to constrain transcription. For example, LeuO
counters silencing of the quiescent porin ompS1 in Salmonella by altering the topology of
the ompS1 promoter region (De la Cruz et al., 2007, De la Cruz et al., 2009) and in
Shigella flexneri, VirB antagonizes H-NS by affecting the structure of the icsB promoter
(Turner & Dorman, 2007).
Our previous work shows that the horizontally acquired, monocistronic icsP gene,
located on the Shigella virulence plasmid, is repressed by H-NS and de-repressed by
VirB. We have demonstrated that the role of VirB is to solely alleviate transcriptional
repression of the icsP promoter, which is mediated by H-NS (Castellanos et al, 2009,
Wing et al., 2004). Surprisingly, two putative VirB binding sites, organized as an
inverted repeat and located over 1 kb upstream of the annotated transcription start site are
indispensible for the de-repression of the promoter (Castellanos et al., 2009). These sites
lie in a designated 1.2 kb intergenic region (Jin et al, 2002); Reference Sequence:
NC_004851.1). Currently, it remains unclear which DNA sequences are required for the
H-NS dependent repression of icsP. Furthermore, although our previous work strongly
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suggests VirB binds directly to this upstream intergenic region, this has never been
categorically demonstrated.
In this study, we further examine the role that H-NS and VirB play in the regulation
of the icsP promoter in an attempt to discern the molecular mechanism responsible. Our
results suggest that both H-NS and VirB regulate the activity of the icsP promoter from
remotely located sequences. We propose a model to explain how silencing and antisilencing of the icsP promoter is achieved by DNA binding-proteins binding to remote
sequence elements. We envisage that an improved understanding of H-NS and VirB
dependent regulation of the icsP promoter will provide insight into bacterial regulation of
transcription from remote sites.
3.2 Materials and Methods
Bacterial strains and plasmids.
The bacterial strains and plasmids used in the present study are given in Appendix 1.
Bacteria were grown routinely at 37 °C in Luria-Bertani broth, with aeration, or on LB
agar (LB broth containing 1.5 % [wt/vol] agar). Antibiotics were added at the following
final concentrations: ampicillin, 100 µg ml-1; chloramphenicol, 25 µg ml-1; kanamycin,
50 µg ml-1; and tetracycline, 12.5 µg ml-1.
Construction of the PicsP-lacZ reporter plasmid and truncated promoter fragments.
The PicsP-lacZ reporter plasmid pHJW20 was used as the basis for this work
(Castellanos et al., 2009, Wing et al., 2004); Table 1). pHJW20 carries 1232 bp
upstream of the annotated transcription start site of the icsP promoter, the first 48 bp of
the icsP coding region cloned upstream of a translation stop site, and a promoterless lacZ
gene, so that expression of lacZ is directly regulated by the icsP promoter. Promoter
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fragments of 1056 bp, 893 bp, 665 bp, 351 bp, 254 bp, 150 bp, and 92 bp, were PCR
amplified and cloned into pHJW20 to replace the 1232 bp icsP promoter (Castellanos et
al., 2009). This created a nested set of PicsP-lacZ fusion plasmids that could be used to
identify regions of the icsP promoter needed for H-NS and VirB-dependent regulation.
All cloned promoters have been sequenced and are identical to the sequence reported for
pCP301 (S. flexneri serotype 2a: NCBI Reference Sequence: NC_004851.1). All
plasmids are described in Appendix 1.
Quantification of icsP promoter activity using the PicsP-lacZ reporter and
derivatives.
Activity of the icsP promoter was determined by measuring β-galactosidase activity
as described previously (Wing et al., 2004) using the Miller protocol (Miller, 1972), in
strains carrying pHJW20 or derivatives. Freshly transformed cells were back-diluted
1:100 in LB and grown at 37 °C for 4 to 5 h to early stationary phase prior to cell lysis,
because icsP expression is maximal under these conditions (Wing et al., 2004). When
appropriate, to examine the effect of expressing virB from the pBAD vectors, cells were
instead back-diluted 1:100 in 5 ml of LB medium containing 0.2% (wt/vol) glucose and,
after 4 to 5 h were harvested, washed with an equivalent volume of LB medium and
diluted 5-fold into LB medium containing either 0.08% (wt/vol) L-arabinose. Cultures
were then grown for an additional 2 h before being harvested. All assays were performed
in triplicate on three separate occasions.
In silico analyses of the icsP promoter and upstream sequences.
The MUTACURVE server (http://132.248.32.45/cgi-bin/mutacurv.cgi) was used to
predict regions of intrinsic DNA curvature. This program evaluates the amplitude of
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intrinsic curvature for every nucleotide in a given sequence using the algorithm of
Goodsell & Dickerson (1994), with the addition of Satchwell’s contribution matrices for
rotational and spatial displacements (Satchwell et al., 1986). These algorithms have been
routinely used by other investigators to identify putative HNS binding sites in DNA
(Beloin & Dorman, 2003, De la Cruz et al., 2009, Flores-Valdez et al, 2003,Will & Frost,
2006).
Construction of inducible plasmids and purification of the VirB and H-NS proteins.
The virB gene was digested from pATM324 using HindIII and NcoI restriction
enzymes and gel purified. The primers W38 and W39 were used to amplify the virB
gene which was then ligated into pQE-60 (Qiagen) before electroporation into E. coli
M15 pREP4 creating a C-terminal His-tagged VirB in an inducible plasmid, pAJH01. A
similar strategy was used to create a C-terminal His-tagged H-NS in an inducible
plasmid, pCTH01. Briefly, the primers W134 and W137 (Appendix 1) were used to
amplify the hns gene from Shigella flexneri serotype 2a with NcoI and BglII sites for
cloning into pQE-60.
His-tagged-VirB and His-tagged-H-NS proteins were overproduced from plasmid
pAJH01, and pCTH01 respectively. Proteins were expressed in the E. coli strain M15
carrying the plasmid pREP4. The expression of the C-terminally His-tagged proteins
were induced in 500 ml cultures growing exponentially with 1mM IPTG (isopropyl-βthiogalactopyranoside). Two hours post-induction, the cells were harvested and frozen at
80 °C overnight. The cell pellet was thawed on ice and resuspended in lysis buffer (40
mM Tris-base [pH 8.93], and 80 mM NaCl). Cells were lysed by sonication, and cellular
debris was pelleted by centrifugation at 10 000 x g at 4 °C. Cell lysates were applied to
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Ni-NTA columns (Qiagen) pre-equilibrated with equilibration buffer (40 mM Tris-base
[pH 8.93], 80 mM NaCl, 10 mM imidazole). The columns were then washed with 10 bed
volumes of wash buffer (equilibration buffer with 20 mM imidazole) prior to elution of
the proteins by the addition of 2.5 bed volume of elution buffer (equilibration buffer with
250 mM imidazole). Eluates were analyzed by SDS-PAGE followed by Coomassie
staining. Purified proteins were dialyzed in equilibration buffer overnight at room
temperature. Protein concentrations were determined using Bradford Assays. The hexahis tag was not found interfere with VirB expression or activity, because His-tagged VirB
was observed to restore IcsP expression to wild type levels in a strain lacking virB in vivo
(data not shown). Furthermore, previous studies using an identical His-tag H-NS fusion
protein, produced in a manner similar to that described above, was shown to retain
normal function of H-NS in assays (Williams & Rimsky, 1997).
Electrophoretic Mobility Shift Assays (EMSAs).
The upstream intergenic region of the icsP promoter (1232 bp) was used as a template
to amplify six, overlapping smaller fragments, ranging from 252 bp to 358 bp by PCR
(Appendix 1). A positive control promoter fragment, icsB, was amplified by PCR using
the Shigella flexneri virulence plasmid as a template, a negative control fragment, pstS,
was amplified from the E. coli genome (Appendix 1) and a non-specific competitor, a
147 bp fragment of DNA from pACYC184 was amplified from pACYC184 by PCR. The
full-length upstream intergenic region of the icsP promoter (icsP’) was also used in
EMSA (generated using primers W63 and W149), as well as a 1011 bp negative control
fragment of the E. coli pstS gene (pstS’) (Appendix 1). 100 nM of each DNA fragment
was incubated with increasing concentrations of purified protein, VirB, H-NS, or both (0
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to 920 nM) for 30 minutes at 30 °C for both VirB and H-NS, in a 20 µl reaction mixture
containing 40 mM Tris-base (pH 8.93), 80 mM NaCl, 1 mM EDTA, 1 mM DTT,
200 ng ml-1 bovine serum albumin (BSA), 200 nM of competitor p184 DNA and 10 %
glycerol. DNA concentrations were measured using the NanoView (GE). The proteinDNA complexes were resolved by electrophoresis in 1.5 % TBE agarose gels for 4 h at
room temperature at 60 V constant. Following electrophoresis, the agarose gels were
stained with ethidium bromide (1 µg ml-1) and visualized using a Typhoon 9410
(Amersham) variable mode imager. EMSAs were performed a minimum of three times
and representative results are shown.
3.3 Results
Identification of regions necessary for the H-NS dependent repression of the icsP
promoter
Although we have demonstrated that DNA sequences located over 1 kb upstream of
the annotated icsP transcription start site are required for VirB-dependent de-repression

Fig. 13. Schematic of the 1.2 kb region located upstream of the icsP gene. Relative positions and
orientation of putative VirB-binding sites are shown (Castellanos et al., 2009). Fragments of
different lengths represents regions DNA cloned upstream of our lacZ reporter in our truncation
series. Coordinates are given in bp and relative to the annotated transcription start site
(characterized by Egile et al., 1997).
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of the icsP promoter (Castellanos et al., 2009), little is known about the sequences
required for H-NS-dependent repression of the icsP promoter. To identify regions of the
icsP promoter required for H-NS-dependent repression we used a nested set of PicsPlacZ fusion plasmids (constructed previously in Castellanos et al., 2009). The promoters
contained within this PicsP-lacZ fusion series share the same downstream boundary, but
their upstream boundaries differ, ranging from -1232 to -351 with respect to the
annotated transcription start site (+1) (Egile et al., 1997) (Fig.13).
Each reporter plasmid was transformed into the E. coli strain MC4100 and an
isogenic strain lacking hns (MC4100 hns). These strains were used to avoid interference
arising from the fact that in Shigella virB is directly regulated by H-NS and the fact that
Shigella hns mutants are notoriously unstable (Maurelli, personal comm.). A similar
strategy has been used by others to study the regulation of other Shigella promoters by HNS (Beloin & Dorman, 2003). A plasmid carrying an inducible copy of the virB gene
was next introduced into each of the E. coli strains (neither strain expresses virB
naturally) so that the effect of H-NS on the icsP promoter could be measured in the
presence and absence of VirB.
The results of the β-galactosidase assay are shown in Fig. 14. In the wild type
background, the four longest promoter fragments had significantly lower activity than in
the hns mutant. These data suggest sequences upstream of -351 are sufficient for H-NSdependent repression, although sequences upstream of -665 are required for full
repression. Induction of VirB in the wild-type background increased the activity of the
longest promoter by 10 fold. This is consistent with data obtained in a Shigella
background (Castellanos et al., 2009) and demonstrates that VirB alleviates H-NS
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dependent repression of the icsP promoter when sequences located over 1 kb upstream of
the annotated transcription start site are present. In the hns mutant background, all
constructs displayed activity higher than 1000 units, regardless of the whether virB was
induced or not. This indicates that H-NS mediates repression of the four longest
constructs in our promoter series and that VirB functions solely to relieve H-NS
dependent repression at the longest construct. Similar observations were made in
previous studies (Wing et al., 2004, Castellanos et al., 2009).

Fig. 14. Activities of the truncated icsP promoter fragments in the presence and absence of H-NS
and /or VirB. Constructs are labeled according to the upstream boundary from the transcription start
site. Bars indicate β-galactosidase expression of the PicsP-lacZ fusions in wild type E. coli MC4100 and
an isogenic strain lacking hns (MC4100 hns::Knr) under inducing and non-inducing conditions for virB
which is included on an inducible plasmid. β -galactosidase activities are expressed in Miller units.
Assays were run in triplicate and error bars represent the mean and standard deviations.

Surprisingly, induction of VirB in the wild type background has a repressive effect on
the activity of the two shortest promoter constructs examined, -665 bp and -351 bp. It is
not clear whether VirB mediates this effect directly, although putative VirB binding sites
have been identified within these fragments (Fig. 4; Castellanos et al., 2009).
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Furthermore, in the context of the shortest promoter construct (-351), the typical role of
H-NS and VirB is reversed; VirB still functions to antagonize H-NS, but now functions
to alleviate H-NS-dependent activation. These data demonstrate that H-NS and VirB are
true molecular antagonists, which, under the right circumstances, can reverse their roles.
This finding provides valuable insight into the molecular mechanisms of transcriptional
silencing and anti-silencing in bacteria. In vitro transcription assays will be performed to
test the hypothesis that H-NS increases the activity of the short promoter constructs.
Taken together, these data demonstrate that sequences located upstream of -351 are
needed for H-NS-dependent repression of the icsP promoter. In the absence of these
upstream sequences, sequences downstream of 351 permit the H-NS-dependent
activation of the icsP promoter. Although H-NS-dependent repression and activation of
these truncated icsP promoter fragments is likely mediated by H-NS binding directly to
DNA sequences located upstream of -351 and downstream of -351, respectively, this
needed testing.
H-NS binds to two
discrete regions upstream
of the icsP gene
In order to determine
whether H-NS binds to
DNA located upstream of
the icsP gene,
electrophoretic mobility
shift assays (EMSAs) were

Fig. 15. Schematic showing the 6 target fragments used in the
EMSAs. Coordinates of each target fragment are given relative
to the transcription start site. Inverted triangles denote the
position of a peak of high intrinsic curvature predicted using the
MUTACURVE program.
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used. The full intergenic region that lies upstream of the icsP gene (1232 bp) was divided
up into six near equal length fragments and each of these fragments were used in EMSAs
with purified His-tagged H-NS (Fig. 15).
For these experiments, a DNA fragment containing sequences that lie between the
divergent icsB and ipgD genes of Shigella flexneri was used as a positive control (icsB),
because H-NS has been shown to bind to this promoter region by others (Turner &
Dorman, 2007) and an internal fragment of the E .coli pstS gene was used as a negative
control (pstS). Each DNA fragment was incubated with increasing concentrations of
purified His-tagged H-NS in the presence of a 147 bp fragment, which had been
amplified from the plasmid pACYC184 and which served as non-specific competitor
DNA (200 nM). DNA and DNA:protein complexes were then resolved by agarose gel
electrophoresis.

Fig. 16. H-NS binding to discrete regions within the icsP upstream intergenic region. EMSAs were
conducted using 100 nM of each fragment shown in Fig. 3 and increasing concentrations of purified Histagged H-NS. The concentrations of purified protein as well as the target fragment used are given above
each lane. In all cases, the lower band is 200 nM of competitor DNA generated from pACYC184.
Positive control, and negative controls are labeled icsB and pstS respectively. 0=no protein, 1=120 nM,
2=230 nM, 3=460 nM,4=920 nM protein.
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Based on previous in vitro studies with H-NS and H-NS-regulated promoters, and due to
the ability of H-NS to oligomerize along DNA, EMSAs performed with H-NS often do
not appear as discrete shifted bands, but are more diffuse (Azam & Ishihama, 1999,
Doyle et al., 2007). Despite this, we fully expected that some of the six DNA fragments
would harbor regions that would interact with H-NS at lower concentrations than others.
Our results show that H-NS binds to target fragments, T6, T5, T4, T3 and T1, with T5
and T4 shifting at the lowest concentration of protein, 120 nM (Fig. 16). The shift of T1
is apparent after incubation with 230 nM of protein while T6 and T3 only shift after
incubation with H-NS concentrations of 460 nM. In contrast, T2 fails to shift in the
presence of H-NS even at high concentrations of H-NS protein (920 nM). In each case,
H-NS binding to the icsP promoter is specific as evidenced by the uniform presence of
free non-specific competitor DNA in all lanes.
The DNA fragments that shift with the lowest concentration of H-NS protein, T5 and
T4, contain sequences located between -1058 to -523 relative to the transcription start
site. This region is present in all constructs that displayed full H-NS-dependent repression
of the icsP promoter in our previous in vivo experiments (Fig 15; promoters with
upstream boundaries of -1056, -893, and -665 all contain sequences contained within
target T5 and T4). These data support our hypothesis that H-NS directly binds to the icsP
upstream intergenic region to mediate H-NS dependent repression. Furthermore, T1 also
shifted with relatively low concentration of H-NS. This fragment contains sequences
located between 213 and +24 relative to the transcription start site. The binding of H-NS
to this region of DNA may explain the H-NS-dependent increase in icsP promoter
activity observed at the shortest promoter construct in our in vivo assays, although this
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still needs to be tested. Also, future studies using DNase I footprint analyses, described
in Chapter 4, will enhance our understanding of the nature of H-NS binding to these
DNA target sequences.
Regions bound by H-NS are predicted to display high levels of intrinsic curvature
H-NS is well documented to bind preferentially to DNA that displays high intrinsic
curvature (Dame et al., 2000, Dorman, 2006, Rimsky et al., 2001). To determine whether
regions lying upstream of the icsP gene are likely to be intrinsically curved, in silico
analysis of the icsP promoter was performed using the MUTACURVE program. Based
on these analyses, five regions were found to display curvature values ≥7°/helical turn.
Since experimentally tested curved motifs produce curvature values of 5–25°/helical turn,
whereas straight motifs give values below 5°/helical turn, our findings are consistent with
these five regions being curved and potentially binding H-NS.
Four of the regions predicted to be intrinsically curved lie upstream of -351 (at
positions -935, -842, -663, -435; data not shown; inverted triangles Fig. 15). In our in
vivo assays this DNA was required for the H-NS dependent repression of the icsP
promoter (Fig. 15). Furthermore, H-NS bound specifically to this DNA in our EMSAs
(Fig. 16). A fifth region of predicted curvature was found to lie around the transcription
start site itself. This may explain why H-NS interacts directly with target 1 in our
EMSAs (Fig. 16) and why this region mediates H-NS dependent activation of the icsP
promoter in our β-galactosidase assays (Fig 14).
The finding that H-NS binds specifically to regions upstream of the icsP gene that are
predicted to be intrinsically curved is consistent with the previously reports that H-NS
display affinity for DNA sequences with high intrinsic curvature (Azam & Ishihama,
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1999, Badaut et al, 2002, Beloin & Dorman, 2003, Berlutti et al., 1998, Bloch et al.,
2003, Bouffartigues et al., 2007, Corcoran & Dorman, 2009, Dorman & Kane, 2009,
Noom et al, 2007, Dame et al., 2000, Dame et al., 2005, Dame et al., 2006, De la Cruz et
al., 2007, De la Cruz et al., 2009, Rimsky et al., 2001, Rimsky, 2004, Turner & Dorman,
2007). Although, more recent work at the proU promoter of E. coli has identified a 10 bp
sequence which binds H-NS with high-affinity (Lang et al., 2007), a rudimentary search
for such a sequence, within the upstream intergenic region of icsP to 100 bp downstream
of the tss, yielded no good matches.
Preliminary experiments designed to test the curvature of these 5 regions, by
electrophoresis in acrylamide gels at room temperature and 4 °C (curved DNA displays
anomalous migration at 4 °C), suggest that these regions are indeed curved (k values all
greater than 1 [k value = ratio of the apparent size of a DNA fragment/ true size of a
DNA fragment; k ≥1 = curved DNA]), however, this needs repeated (data not shown; De
la Cruz et al., 2009, Prosseda et al., 2004).
VirB binds to the intergenic region that lies upstream of the icsP gene
Our previous studies revealed that sequences located 1 kb away from the annotated
transcription start site are absolutely required for the VirB dependent regulation of icsP
activity (Castellanos et al., 2009). It remains unclear, however whether VirB binds
directly to the icsP promoter or mediates is effect indirectly through another VirBregulated protein. To test this, EMSAs using purified His-tagged VirB protein were used.
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Fig. 17. VirB and H-NS binding of the full length icsP upstream intergenic region. EMSA results of
the long, >1 kb, DNA fragments. a) shows the shift the full length icsP upstream intergenic region
(icsP’), compared to the negative control, the 1011 bp fragment of the E. coli pstS (pstS’), b) shows HNS the shift of the full length icsP upstream intergenic region (icsP’), compared to the negative control.
The concentrations (nM) of purified protein are given above each lane with the identity of the target given
below. In all cases the lower band represents 200 nM of non-specific competitor DNA derived from
pACYC184.

The full upstream intergenic region of the icsP promoter (icsP’; 1232 bp) was
incubated with increasing concentrations of purified His-tagged VirB. Again, an internal
fragment of the E. coli pstS gene was used as a negative control for these experiments,
but a longer fragment (1011 bp) was used to mirror the increased length of the fragment
of interest. As previously described, a 147 bp fragment amplified from the plasmid
pACYC184 (p184; 200 nM) was included in each reaction as a non-specific competitor
DNA and DNA:protein complexes were resolved by agarose gel electrophoresis.
Our data show that a DNA fragment amplified from the entire intergenic region (1232
bp) located upstream of the icsP gene, was retarded by 230 nM of VirB, with complete
retardation after incubation with 460 nM of VirB (Fig. 17a). The binding of VirB to this
DNA was specific at concentrations between 230-460 nM, because VirB does not bind to
the non-specific competitor DNA p184 nor the negative control fragment pstS’ at these
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concentrations. Some non-specific binding to the pstS’ fragment was observed at VirB
concentrations above 460 nM, however.
Although the VirB-dependent shift of the upstream intergenic region appears as a
smear in these EMSAs, this appears to be a characteristic of VirB:DNA interaction in
vitro, because Turner & Dorman (2007) reported similar observations when studying
VirB:DNA interactions with the Shigella icsB promoter by EMSAs. Furthermore,
although the magnitude of the shift is not as dramatic as commonly seen in EMSAs using
DNA fragment of approximately 100-300 bp, it should be remembered that the DNA
probe in these experiments much larger. It is likely that this accounts for the moderate
shift observed. Regardless, there is a specific loss of free icsP’ probe DNA with
increasing concentrations of protein. We therefore conclude that VirB binds directly to
the 1.2 kb region that lies immediately upstream of the icsP promoter, and this binding is
likely required for the VirB-dependent regulation of the icsP promoter.
H-NS does not bind to discrete regions upstream of the icsP gene cooperatively
Both our in vivo and in vitro data strongly suggests that H-NS binds to two discrete
regions upstream of the icsP gene (upstream of -351 and downstream of -213). We next
wanted to determine whether H-NS binds cooperatively to these regions when these
regions are juxtaposed in the context of the whole upstream intergenic region. If so, we
predicted that lower concentrations of H-NS would be required to bind the whole region
upstream of the icsP gene than fragments of it.
To test this the full length upstream intergenic region (1232 bp; icsP’) and the
negative control fragment (1011 bp internal to the pstS gene; pstS’) were incubated with
increasing concentrations of purified His-tagged H-NS protein and then resolved by
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agarose gel electrophoresis. Our results show that again H-NS binds to the upstream
intergenic region and not to the negative control or the non-specific competitor (Fig.
17b). The H-NS dependent shift of the icsP’ fragment begins at 230 nM of protein with
near complete retardation of the DNA probe by 920 nM. Furthermore the shift observed
with the full upstream intergenic region, occurs at approximately the same concentration
(230 nM) as the shift observed when some of the short DNA fragments were incubated
with H-NS (Fig. 16). These data suggest that H-NS binds to the full length icsP upstream
intergenic region as efficiently as it binds to some of the smaller DNA fragments used in
our previous EMSA experiment, but not better. This indicates that H-NS binding to the
entire intergenic region upstream of the icsP gene does not occur cooperatively, at least
in vitro.
H-NS and VirB bind simultaneously to DNA located upstream of the icsP gene in
vitro
Our current understanding of the mechanism of silencing/anti-silencing at the icsP
promoter involves H-NS binding to regions of DNA with high intrinsic curvature and
VirB antagonizing H-NS-DNA-H-NS bridges, allowing transcription to occur. This
understanding is based on work conducted by others, which has examined the interaction
of H-NS with other DNA binding proteins (De la Cruz et al., 2007, Hulbert & Taylor,
2002, Huo et al, 2009). What remains unclear about this mechanism of transcriptional
regulation is whether VirB causes H-NS to dissociate from the DNA, or whether VirB
simply displaces H-NS, resulting in both proteins binding simultaneously to the DNA.
To shed light on the mechanism of transcriptional silencing and anti-silencing at the icsP
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promoter, we chose to study whether VirB and H-NS interacts simultaneously with the
DNA using EMSAs.
The full upstream intergenic region (icsP’; 1232 bp) and our negative control (1011
bp; pstS’) were first incubated with VirB alone (460 nM) or H-NS alone (1.8 µM). In the
second part of the experiment, the icsP’ DNA fragment and the negative control pstS’
was pre-incubated with 1.8 µM of H-NS before the addition of increasing concentrations
of VirB (120, 240 & 460 nM).

Fig. 18. VirB and H-NS binding of the icsP upstream intergenic region in vitro. EMSA results
using the full length icsP’ and pstS’ are shown. Lanes 2 and 8 contain 460 nM purified VirB. Lanes 3
and 9 contain 1.8 µM purified H-NS. Lanes 4-6 and 10-12 were pre-loaded with 1.8 µM H-NS before
increasing concentrations of VirB, 120 nM, 230 nM, and 460 nM, were added. The lower band is 200
nM of competitor DNA generated from pACYC184.
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As predicted, when VirB or H-NS were incubated independently with the DNA
fragments (Fig. 18; lanes 2 & 8, 3 & 9), the icsP’ fragment alone was retarded in the gel
matrix indicating the formation of specific nucleoprotein complex. This is consistent
with our previous observations (Fig. 17a & b). Interestingly though, when DNA
fragments were pre-loaded with H-NS and then incubated with 460 nM of VirB (Fig. 9,
lanes 6 & 9), DNA-protein complexes formed on the icsP’ fragment that migrate slower
than complexes formed by each protein individually. These data suggest that under these
experimental conditions, VirB and H-NS simultaneously bind to the icsP’ DNA
fragment. This could occur if VirB is displacing H-NS along the DNA or reorganizing
the nucleoprotein complex, rather than causing the dissociation of H-NS from the DNA.
Although it is likely that both proteins have remained associated with the DNA, future
experiments will detect whether both protein species are present in the higher molecular
weight complex by using mass spectroscopy, and immunodetection.
3.4 Discussion
Nucleoid structuring proteins play important roles in gene silencing in many bacterial
species (Azam & Ishihama, 1999). Gene silencing in bacteria usually involves the
formation of a nucleoprotein complex that renders the DNA inaccessible to DNA-binding
proteins that are required for transcription (Azam & Ishihama, 1999, Dorman & Deighan,
2003, Yarmolinsky, 2000). Transcription factors that alleviate this silencing are central
to bacterial physiology and regulate a variety of bacterial processes including virulence
gene expression, biofilm formation, and bacterial adaptation to stress (Stoebel et al.,
2009). The mechanisms of silencing and anti-silencing, however, are still being
elucidated.
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While it has been established that H-NS is a global repressor of horizontally acquired
genes what remains elusive is a complete picture of how H-NS represses transcription
and how it is alleviated by other transcription factors. In this work, we have focused on
the regulation of the icsP gene encoded by the Shigella virulence plasmid. We describe
regions necessary for the H-NS dependent repression of the icsP promoter and regions
responsible for the binding of the global repressor H-NS and the major virulence factor
VirB.
Our data show that H-NS represses icsP promoter activity and that VirB alleviates
this repression (Castellanos et al., 2009). Through deletion analysis of the icsP upstream
intergenic region and in vivo assays, we have identified that sequences upstream of -665
(with respect to the icsP annotated transcription start site [tss]) are needed for full
repression of activity the promoter, although sequences between -665 and -351 appear
sufficient for partial repression. Although it is unusual for H-NS to impart its effects
from so far upstream of the transcription start site, our truncation analysis of the icsP
upstream intergenic region has shed light on how this remote regulation might occur.
We observed that the removal of DNA sequences upstream of -351 resulted in an HNS-dependent increase in promoter activity. The simplest interpretation of these data is
that H-NS interacts directly with sequences downstream of -351 leading to an increase in
the activity of the promoter. This is corroborated by our EMSA data, which shows
specific binding of H-NS to sequences between –213 and +24 with relatively high
affinity. Taken together, our data strongly suggests that H-NS binds to two discrete
regions (upstream of -351 and downstream of -213) that lie upstream of the icsP gene and
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that these two regions are separated by a region with little to no affinity for HNS (regions
contained within T2 in Fig. 13).
H-NS has been demonstrated to oligomerize along DNA (Rimsky et al., 2001, Turner
& Dorman, 2007), and form H-NS-DNA-H-NS bridges, which are described as looped
DNA structures constrained by H-NS (Maurer et al., 2009, Stoebel et al., 2009). Based
on this work, it is tantalizing to imagine H-NS docked to upstream sites interacting with
H-NS docked to downstream sites to mediate repression of the icsP promoter. Although,
it is unusual for “classical” transcription factors to influence transcription from DNA
binding sites located over 500 bp away, atomic force microscopy has revealed that H-NS:
DNA: HNS bridges may involve long stretches of DNA, extending over 1 kb (Maurer et
al., 2009), and these structures have been documented to play important roles in promoter
silencing (Dame et al., 2000, Dame et al., 2005, Dame et al., 2006). Although we have
no evidence to support the involvement of downstream sites in the H-NS mediated
repression of the icsP promoter so far, this is currently being tested.
H-NS is well documented as displaying a binding preference for regions of DNA that
are AT rich (Dame et al., 2005, Dame et al., 2006, De la Cruz et al., 2009, Dorman,
2009a, Dorman, 2009c, Porter & Dorman, 1994, Rimsky et al., 2001, Shin et al., 2005,
Stoebel et al., 2008, Turner & Dorman, 2007, Williams et al., 1996, Williams & Rimsky,
1997, Zhang et al., 1996). These sequences typically display high levels of intrinsic
curvature (Zuber et al., 1994). The work presented here demonstrates that regions
upstream of the icsP gene, which bind H-NS, coincide with regions predicted to be
intrinsically curved, as determined by the MUTACURVE server
(http://132.248.32.45/cgi-bin/mutacurv.cgi). Although more recent work has revealed the
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presence of a high affinity binding sequence for H-NS at the E. coli proU promoter
(Bouffartigues et al. 2007, Lang et al., 2007) this 10 bp sequence was not found within
the full-length fragment, which constitutes the intergenic region upstream of the icsP
gene. This suggests that H-NS recognizes sequences other than those proposed by
Bouffartigues et al. (2007) and Lang et al., (2007). It is possible that future
investigations, using DNase I footprinting, may identify other sequences with high
affinity for H-NS, which would initiate H-NS binding and oligomerization along the
DNA.
Our previous studies revealed that VirB functions to derepress the icsP promoter and
that two VirB-binding sites organized as inverted repeat and located over 1 kb upstream
of the annotated icsP transcription start site are required for VirB-mediated derepression
(Castellanos et al., 2009). This work is corroborated by the β-galactosidase data
presented here. Using EMSAs we demonstrate that VirB binds to the full upstream
intergenic region of the icsP promoter. This is the first indication that VirB interacts
directly with the icsP promoter, and we hypothesize that this binding is important for derepression of the full-length promoter.
While our previous work strongly suggests that VirB interacts directly with the two
VirB-binding sites located over 1 kb upstream of the icsP tss (Castellanos et al., 2009),
our in vivo assays suggests that VirB may also interact with promoter proximal
sequences. In these experiments VirB was found to antagonize H-NS dependent
“activation” of the icsP promoter in the shortest construct tested. Although, this effect
has the potential to be mediated by a VirB-regulated protein, the simplest interpretation
of these results is that VirB interacts directly with sequence downstream of -351 to
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mediate this effect. Four putative VirB binding sites have been identified in this region,
although none of these are organized as inverted repeats. It remains unclear whether any
of these, or other sites, mediates this VirB-dependent repression of the short fragments or,
indeed, what they play in derepression of promoter in the context of the full upstream
intergenic region. Future investigations will assess the role that these downstream
putative VirB-binding sites play in the regulation of the promoter.
The results obtained with the shortest construct in our truncation series are
interesting for another reason; in the context of this construct, both H-NS and VirB
reverse their “typical” roles, H-NS leads to an increase in promoter activity and VirB
dampens this effect. Although, it is well established that DNA binding proteins can serve
dual roles, usually this phenomenon is dependent upon the location of the protein binding
site (Corcoran & Dorman, 2009, Browning et al, 2000). Our data suggest, at least in the
case of the icsP upstream intergenic region, the context each protein finds itself in with
respect to the transcription start site and to the other protein, may determine whether the
protein serves as an activator or repressor. These findings provide valuable insight into
the plasticity of the molecular mechanisms that leads to transcriptional silencing and antisilencing in bacteria.
Based on our findings, we are able to propose a model of transcriptional silencing and
anti-silencing at the icsP promoter which involves the use of remotely located binding
sites. At the non-permissive temperature of 30 ˚C, H-NS binds to upstream and
downstream region in the intergenic region that lies upstream of the icsP promoter. This
allows the formation of an H-NS-DNA-H-NS loops or bridges between promoter distal
(upstream of -665) and promoter proximal sequences (downstream of -213). At the
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permissive temperature of 37˚C, the temperature at which VirB is maximally expressed,
VirB binds to the essential VirB-binding sites organized as an inverted repeat and located
at position - 1144 with respect to the tss. Although, the distance over which VirB
mediates its effect is unusual, if this protein functions to solely antagonize H-NSmediated repression of the promoter, VirB may not need to bind to sites located in the
vicinity to the icsP promoter in order to mediate transcriptional de-repression,
eventhough putative binding sites have been found. Regardless of which sites are
engaged by VirB, our EMSAs suggest that the interaction of VirB with the full upstream
intergenic region does not cause H-NS to dissociate from the DNA. Instead, it seems
more likely that VirB functions to reorganizes the nucleoprotein complex, which
ultimately leads to the formation of a complex that is permissive for transcription to occur
at the icsP promoter. This model will be used to frame our future studies of the icsP
promoter region and transcriptional silencing and anti-silencing mechanisms.
In conclusion, this study raises several questions that are central to virulence gene
expression in Shigella and other enteric pathogens and which lie at the heart of bacterial
physiology. How does VirB function to alleviate H-NS dependent repression of the icsP
promoter from such distances? Does VirB function from remote sites to regulate the
expression of other Shigella virulence genes? Can transcription factors found in other
bacteria function from remote sites to alleviate transcriptional repression by nucleoid
structuring proteins? If so, how widespread is this phenomenon? We anticipate that these
questions will be answered as transcriptional silencing and anti-silencing mechanisms in
bacteria continue to be studied.
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CHAPTER 4
VIRB AND H-NS BIND TO THE ICSP PROMOTER OF SHIGELLA FLEXNERI
AND THE ROLE OF STATIC DNA CURVATURE IN THE
REGULATION OF ICSP
Abstract
In the bacterial pathogen Shigella flexneri, many genes encoded by the large
virulence plasmid are repressed by the nucleoid structuring protein H-NS and derepressed by the major virulence gene activator VirB. One example is the icsP gene,
which encodes an outer membrane protease. Using electrophoretic mobility shift assays
(EMSAs), and DNase I footprinting analysis we show that VirB binds directly to the
upstream intergenic region of icsP and demonstrate that VirB binds to DNA sequences
located promoter distally and proximally. These data support a model where VirB bound
to remote sites may act in concert with VirB bound to promoter proximal sequences to
mediate VirB dependent de-repression of the icsP promoter. We show that the disruption
of regions displaying high intrinsic curvature do not have an effect on either the ability of
H-NS to repress promoter activity or VirB to alleviate this repression, at least in the
context of the full upstream intergenic region. Our findings enhance our understanding
of the mechanism of transcriptional silencing and anti-silencing that control virulence
gene expression in Shigella and raise the possibility that other bacterial promoters may be
regulated from remote transcription factor binding sites.
Authors: Dustin J Harrison and Helen J Wing
We thank Dr. Eric Anderson and Dr. Martin Roop from East Carolina University for all
their help and guidance with the EMSAs, and Stephanie Labahn for technical support.
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4.1 Introduction
Shigella species are gram-negative intracellular pathogens that cause bacillary
dysentery in humans. Shigella infections are responsible for approximately 164 million
infections each year resulting in 1.1 million deaths, most of these occur in developing
countries and in children less than 5 years old (Kotloff et al., 1999, Lee et al., 2005, Li et
al., 2009). All four Shigella species carry a large (230 kbp) virulence plasmid. Many
genes encoded by these plasmids are under the transcriptional control of the histone-like
nucleoid structuring protein (H-NS) and the major virulence gene activator VirB (Adler
et al., 1989, Berlutti et al., 1998).
H-NS is a nucleoid structuring protein that is well characterized as a silencer of
bacterial transcription (Ali Azam et al., 1999, Dorman, 2004). H-NS has been shown to
oligomerize on DNA (Rimsky et al., 2001, Turner & Dorman, 2007) and this
oligomerization can lead to the formation of H-NS-DNA-H-NS bridges, which have been
visualized using atomic force microscopy as looped DNA structures constrained by H-NS
(Maurer et al., 2009). These structures may involve long stretches of DNA, extending
over 1 kb (Dame et al., 2000, Dame et al., 2005, Dame et al., 2006, Maurer et al., 2009),
and have been documented as playing important roles in promoter silencing
(Bouffartigues et al., 2007, De la Cruz et al., 2009, Dorman, 2004, Dorman, 2009a, Fang
& Rimsky, 2008, Navarre et al., 2006, Stoebel et al., 2008). Disruption of these HNS:DNA complexes by other DNA-binding proteins can allow transcriptional derepression; a process coined anti-silencing (Fang & Rimsky, 2008, Navarre et al., 2007,
Stoebel et al., 2008).
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The virulence gene activator VirB is encoded by the Shigella virulence plasmid and
its expression is regulated by another transcription factor VirF (Adler et al., 1989). At
the non-permissive temperature of 30 ˚C many genes encoded by the virulence plasmid
are repressed by H-NS (Beloin & Dorman, 2003, Hromockyj et al., 1992, Porter &
Dorman, 1994). Upon a switch to 37 °C, a change in DNA superhelicity causes H-NS to
dissociate from the virF promoter leading to the production of the virulence gene
regulator, VirF (Adler et al., 1989). VirF relieves H-NS-dependent repression of the virB
promoter (Tobe et al., 1993, Watanabe et al., 1990) and subsequently VirB alleviates HNS dependent repression of many virulence plasmid genes, including icsA and those
encoding the type III secretion system that mediate host cell invasion; ipa, mxi and spa
(Beloin & Dorman, 2003, Berlutti et al., 1998, Dorman, 2006, Hromockyj et al., 1992,
Maurelli et al., 1984a, Maurelli et al., 1984b, Nicoletti et al., 2008, Porter & Dorman,
1994, Porter et al., 1998, Prosseda et al., 1998, Sasakawa et al., 1993, Tobe et al., 1991,
Tobe et al., 1993, Tobe et al., 1995). Transcriptional de-repression (anti-silencing) of
virulence genes by VirF and VirB is central to the pathogenicity of Shigella.
The mechanism underlying transcriptional silencing/anti-silencing has been proposed
to be a straightforward molecular antagonism involving competition between the
silencing protein and the anti-silencing protein for their overlapping cognate DNA
binding sequences, which are usually located in the immediate vicinity of the promoter.
Typically this competition results in the dissociation of the silencing molecule from the
DNA (Fang & Rimsky, 2008, Navarre et al., 2007). In contrast, at some bacterial
promoters the anti-silencing proteins function to alter the DNA topology in a way that no
longer allows H-NS to constrain transcription. For example, LeuO counters silencing of
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the quiescent porin ompS1 in Salmonella by altering the topology of the ompS1 promoter
region (De la Cruz et al., 2007, De la Cruz et al., 2009) and in Shigella flexneri, VirB
antagonizes H-NS by affecting the structure of the icsB promoter (Turner & Dorman,
2007). Previous analysis of the icsB, spa15 and virA promoters of Shigella sonnei, and
icsB from S. flexneri, established a consensus binding site for VirB. Our analysis of
sequences upstream of the icsP gene identified nine sites with greater than a 6/7 match to
the consensus, 5’-(A/G)(A/T)G(G)AAAT-3’ (Fig. 12B; Taniya et al, 2003, Turner &
Dorman, 2007).
Genome-wide studies have revealed that intrinsically curved DNA in the promoter
regions of a large proportion of many important bacteria may constitute one of the most
conserved and primitive forms of transcriptional regulation before the co-evolution of
trans-acting factors that recognize bent DNA, e.g. DNA binding proteins (KozobayAvraham et al, 2004, Prosseda et al, 2010). Static curvature of DNA has been shown to
activate transcription, by facilitating RNA polymerase (RNAP) binding to promoters, as
well as the nucleoid proteins IHF, and Fis which both recognize curved DNA and allow
enhanced transcription initiation (Prosseda et al, 2004, Prosseda et al., 2010, Falconi et
al, 1998, Falconi et al, 2001, Olivares-Zavaleta et al, 2006, Dorman & Deighan, 2003,
Luijsterburg et al, 2006). On the other hand, the static curvature of DNA can play an
indirect role in the transcriptional repression allowing silencers like H-NS to engage
DNA to stabilize or enhance a preexisting DNA loop that blocks transcription (Prosseda
et al., 2004, Falconi et al., 1998). Therefore, curvature is an important determinant in the
regulation of promoter activity. Many related bacterial species including E. coli,
Salmonella, and Yersinia have global transcription factors, as well as specific regulators,
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that regulate promoters with curved DNA, and we anticipate that the Shigella icsP
promoter is no exception. In Prosseda et al. (2004), De la Cruz et al. (2009), and Falconi
et al. (1998) disruption of a region of curved DNA had significant effects on the ability of
transcriptional regulators to exert their effects highlighting the importance that curved
sequences have on transcriptional regulation.
Our previous work shows that the icsP gene, located on the Shigella virulence
plasmid, is repressed by H-NS and de-repressed by VirB. We have demonstrated that the
role of VirB is to solely alleviate transcriptional repression of the icsP promoter mediated
by H-NS from sites over 1 kb upstream of the annotated transcription start site (Harrison
et al., under revision, Castellanos et al., 2009, Wing et al., 2004). Surprisingly, two
putative VirB binding sites, organized as a perfect inverted repeat, are found in the
extreme distal region of the icsP upstream intergenic region and are essential for the VirB
dependent regulation of icsP in vivo (Castellanos et al., 2009). Although our previous
work strongly suggests VirB binds directly to this upstream intergenic region, this has
never been categorically demonstrated.
In this study, we examine further the role that VirB plays in the regulation of the icsP
promoter in an attempt to discern the molecular mechanism responsible, as well as
examining the effect that regions of intrinsic curvature have on promoter activity in the
presence and absence of both H-NS and VirB. Our results suggest that VirB regulates the
activity of the icsP promoter by binding directly to the upstream intergenic region of
icsP. Our data also suggest that disruption of a single peak of intrinsic curvature in the
context of the full upstream intergenic region does not have an effect on the H-NS
mediated repression, or the VirB dependent de-repression of the promoter. We propose a
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model to explain how silencing and anti-silencing of the icsP promoter is achieved by
DNA binding-proteins binding to remote sequence elements. An improved
understanding of the H-NS and VirB dependent regulation of the icsP promoter will
provide insight into bacterial regulation of transcription from remote sites.
4.2 Materials and Methods
Bacterial strains, plasmids and media.
The bacterial strains and plasmids used in the present study are listed in Appendix 1.
Bacteria were grown routinely at 37°C in Luria-Bertani (LB) broth with aeration or on
LB agar (LB broth containing 1.5% [wt/vol] agar). Antibiotics were added at the
following final concentrations: ampicillin, 100 µg/ml; chloramphenicol, 25 µg/ml;
kanamycin, 50 µg/ml; and tetracycline, 12.5 µg/ml. Where appropriate, to ensure that
Shigella strains had maintained the large virulence plasmid during manipulation, Congo
red binding was tested on Trypticase soy broth agar plates containing 0.01% (wt/vol)
Congo red (Sigma Chemical Co., St. Louis, Mo.).
Construction of the PicsP-lacZ reporter plasmid and site directed mutagenesis of
PicsP.
The PicsP-lacZ reporter plasmid pHJW20 was used as the basis for this work
(Castellanos et al., 2009, Wing et al., 2004; Appendix 1). pHJW20 carries 1232 bp
upstream of the annotated transcription start site of the icsP promoter, the first 48 bp of
the icsP coding region cloned upstream of a translation stop site, and a promoterless lacZ
gene, so that expression of lacZ is directly regulated by the icsP promoter.
Site-directed mutagenesis was performed using the Quick Change Lightning II kit
(Stratagene) according to manufacturer instructions. Complimentary oligonucleotides
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containing the mutations predicted by MUTACURVE were used to disrupt/restore the
curvature of the icsP promoter in the template plasmid pNEO1 (Appendix 1).
Following mutation, the 1232 bp insert was digested using PstI, PacI and cloned into
pDH01 creating 4 plasmids designed to disrupt (D) curvature and 4 plasmids designed to
restore (R) curvature around the predicted peaks of highest intrinsic curvature: pMut1
D/R (-842), pMut 2 D/R (-935), pMut 3 D/R (-663), pMut 4 D/R (-435) (Appendix 1;
Table 4 and 5). All promoters have been sequenced. All primers and plasmids are
described in Appendix 1.
Quantification of icsP promoter activity using the PicsP-lacZ reporter and
derivatives.
Activity of the icsP promoter was determined by measuring β-galactosidase activity
(Wing et al., 2004) by using the Miller protocol (Miller, 1972) in strains carrying
pHJW20 or derivatives. Freshly transformed cells were back-diluted 1:100 and grown
for 4 to 5 h in either TSB medium (S. flexneri) or LB (E. coli) at 37°C prior to cell lysis
because icsP expression significantly increases under these conditions (Wing et al.,
2004). Assays were performed in triplicate on three separate occasions.
In silico analyses of the icsP promoter and upstream sequences.
Prediction of intrinsic DNA curvature was done using MUTACURVE
(http://132.248.32.45/cgi-bin/mutacurv.cgi). The MUTACURVE program evaluates the
amplitude of intrinsic curvature for every nucleotide in a given sequence using the
algorithm of Goodsell & Dickerson (1994), with the addition of Satchwell’s contribution
matrices for rotational and spatial displacements (Satchwell et al., 1986). These
algorithms have been routinely used by other investigators to identify putative H-NS
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binding sites in DNA (Beloin & Dorman, 2003, De la Cruz et al., 2009, Flores-Valdez et
al., 2003, Will & Frost, 2006).
Construction of inducible plasmids and purification of the VirB and H-NS proteins.
The virB gene was digested from pATM324 using HindIII and NcoI restriction
enzymes and gel purified. The primers W38 and W39 were used to amplify the virB
gene, which was then ligated into pQE-60 (Qiagen) before electroporation into E. coli
M15 pREP4 creating a C-terminal His-tagged VirB in an inducible plasmid, pAJH01. A
similar strategy was used to create a C-terminal His-tagged H-NS in an inducible
plasmid, pCTH01. Briefly, the primers W134 and W137 (Appendix 1) were used to
amplify the hns gene from Shigella flexneri serotype 2a with NcoI and BglII sites for
cloning into pQE-60.
His-tagged-VirB and His-tagged-H-NS proteins were overproduced from plasmid
pAJH01, and pCTH01 respectively. Proteins were expressed in the E. coli strain M15
carrying the plasmid pREP4. The expression of C-terminally His-tagged proteins was
induced in 500 ml cultures growing exponentially with 1mM IPTG (isopropyl-βthiogalactopyranoside). Two hours post-induction, the cells were harvested and frozen at
80 °C overnight. The cell pellet was thawed on ice and resuspended in lysis buffer (40
mM Tris-base [pH 8.93], and 80 mM NaCl). Cells were lysed by sonication, and cellular
debris was pelleted by centrifugation at 10 000 x g at 4 °C. Cell lysates were applied to
Ni-NTA columns (Qiagen) pre-equilibrated with equilibration buffer (40 mM Tris-base
[pH 8.93], 80 mM NaCl, 10 mM imidazole). The columns were then washed with 10 bed
volumes of wash buffer (equilibration buffer with 20 mM imidazole) prior to elution of
the proteins by the addition of 2.5 bed volume of elution buffer (equilibration buffer with

77

250 mM imidazole). Eluates were analyzed by SDS-PAGE followed by Coomassie
staining. Purified proteins were dialyzed in equilibration buffer overnight at room
temperature. Protein concentrations were determined using Bradford Assays. The hexahis tag was not found interfere with VirB expression or activity, because His-tagged VirB
was observed to restore IcsP expression to wild type levels in a strain lacking virB in vivo
(data not shown). Furthermore, previous studies using an identical His-tag H-NS fusion
protein, produced in a manner similar to that described above, was shown to retain
normal function of H-NS in assays (Williams & Rimsky, 1997).
Electrophoretic Mobility Shift Assays (EMSAs).
The upstream intergenic region of the icsP promoter (1232 bp) was used as a template
to construct six, overlapping smaller fragments, ranging from 252 bp to 358 bp by PCR
(Appendix 1). A positive control fragment, icsB, was made by PCR using the Shigella
flexneri virulence plasmid as a template and the negative control, an internal fragment of
pstS, was made using E. coli genomic DNA as the template (Appendix 1). As a nonspecific competitor, a 147 bp fragment of DNA from pACYC184 was generated by PCR.
The PCR probe fragments were incubated with increasing concentrations of purified
protein, VirB (0 to 920 nM) for 30 minutes at 30°C in a 20 µl reaction mixture containing
40 mM Tris-base (pH 8.93), 80 mM NaCl, 1 mM EDTA, 1 mM DTT, 200 ng/ml bovine
serum albumin (BSA), 200 nM of competitor p184 DNA and 10% glycerol. Each
reaction mixture contained approximately 100 nM of DNA, measured using the
NanoView (GE). The protein-DNA complexes were resolved by electrophoresis in 1.5%
TBE agarose gels for 4 hours at room temperature at 60 V constant. Following
electrophoresis the agarose gels were stained with ethidium bromide (1 µg/ml), and
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visualized using a Typhoon 9410 (Amersham) variable mode imager. EMSAs were
performed a minimum of three times with representative results shown.
DNase I footprinting.
Fragments of the icsP promoter were amplified by PCR (Appendix 1) before being
restriction digested using SalI and EcoRI, and ligated into a pBluescript (Stratagene)
vector. The ligated plasmids were transformed by electroporation into E. coli DH10B
cells and plated to media containing ampicillin (100 µg/ml). Sequence analysis
confirmed the presence of the correct icsP target sequence. Overnight cultures of DH10B
with the holding vector plasmids were grown overnight and back diluted 1/100 into 500
ml cultures of LB containing ampicillin. The cells were harvested by centrifugation and
plasmids purified by Qiagen Mega-prep (Qiagen). Aliquots of Mega-preps were then
digested with SalI, or EcoR1, followed by calf intestinal alkaline phosphate (CIAP)
digestion to remove the terminal phosphate. Phenol:chloroform extraction removed the
CIAP followed by ethanol precipitation. Plasmids were next digested with SalI, or
EcoR1, before being purified by native acrylamide gel electrophoresis. Excised bands
were extracted from the acrylamide and a PCR clean-up kit was used (Qiagen) before T4
kinase end labeling with [γ32P]ATP. End labeled products were cleaned using illustra
ProbeQuant G-50 Micro Columns (GE Healthcare) to remove unincorporated
radionucleotides.
Increasing amounts of VirB or H-NS protein were incubated for 30 min at 30° C
with a labeled probe (~200 nM of DNA) in binding buffer (40 mM Tris-base [pH 8.93],
80 mM NaCl, 1 mM EDTA, 1 mM DTT, 200 ng/ml bovine serum albumin [BSA], 25
µg/ml sonicated Herring sperm DNA, 200 nM of competitor p184 DNA, and 10%
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glycerol) with protein buffer (40 mM Tris-base [pH 8.93], 80 mM NaCl, 1 mM EDTA, 1
mM DTT, and 10% glycerol) to a final volume of 20 µl. DNase I diluted 1:100 in 4 mM
Tris-base (pH 8.93), 8 mM NaCl, 0.5 mM CaCl2, and 40 mM Mg Cl2, was added to the
reaction mixtures at 30° C and incubated for 40 seconds. The addition of stop solution
(0.3M sodium acetate, and 5 mM EDTA) stopped the reactions. DNA was extracted with
200 µl of phenol:chloroform followed by ethanol precipitation. DNA was
electrophoresed through a 6% polyacrylamide sequencing gel run at 60 Watts constant
until the bromophenol blue dye front migrated out of the gel. Following completion of
the electrophoresis the gel was dried and exposed to a phosphor-imaging screen and
viewed on a Typhoon 9410 variable mode imager. Protected bands were identified by
comparison to a DNA sequencing ladder generated using the method of Maxam and
Gilbert (Maxam & Gilbert, 1986). Experiments were conducted a minimum of three
times with representative images shown.
4.3 Results and Discussion
VirB binds the upstream intergenic region of icsP.
Our previous work has demonstrated the VirB dependent regulation of icsP and that
VirB functions solely to alleviate the H-NS dependent repression of promoter activity
(Castellanos et al., 2009, Harrison et al., under revision). Harrison et al., (under revision;
CH 3) showed VirB binds to the full upstream intergenic region upstream of the icsP
gene. However, to determine which sequences are required for VirB to bind, we again
used electrophoretic mobility shift assays (EMSAs). The full upstream intergenic region
that lies upstream of the icsP gene (1232 bp) was divided up into six near equal length
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fragments and each of these fragments were used in EMSAs with purified His-tagged
VirB (Fig. 19).
For these
experiments, a DNA
fragment containing
sequences that lie
between the divergent
icsB and ipgD genes of
Shigella flexneri was
used as a positive control

Fig. 19. From Harrison, et al., under revision, CH 3, schematic
showing the 6 target fragments used in the EMSAs. Coordinates
of each target fragment are given relative to the transcription start
site. Inverted triangles denote the position of a peak of high
intrinsic curvature predicted using the MUTACURVE program.

(icsB), because VirB has been shown to bind to this promoter region by others (Turner &
Dorman, 2007) and an internal fragment of the E .coli pstS gene was used as a negative
control (pstS). Each DNA fragment (100 nM) was incubated with increasing
concentrations of purified His-tagged VirB in the presence of a 147 bp fragment, which
had been amplified from the plasmid pACYC184 and which served as non-specific
competitor DNA (200 nM). DNA and DNA:protein complexes were then resolved by
agarose gel electrophoresis.
Previous in vitro studies with VirB and VirB-regulated promoters have shown that the
DNA band in EMSAs performed with VirB often do not appear as discrete shifts but are
more diffuse which has been proposed to be evidence of protein oligomerization (Turner
& Dorman, 2007). Despite this, we anticipated that VirB would interact with with some
of the DNA fragments at lower concentrations than others, in particular T6 which
contains putative VirB binding sites that were absolutely required for the VirB dependent
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Fig. 20. VirB binding within the icsP upstream intergenic region. EMSAs were conducted using 100
nM of each fragment shown in Fig. , as well as T6 - (mutated VirB binding site, from Castellanos et al.,
2009) and increasing concentrations of purified His-tagged VirB. The concentrations of purified protein as
well as the target fragment used are given above each lane. In all cases, the lower band is 200 nM of
competitor DNA generated from pACYC184. Positive control, and negative controls are labeled icsB and
pstS respectively. 0=no protein, 1 = 120 nM, 2 =230, 3=460 nM protein.

de-repression of icsP promoter activity (Castellanos et al., 2009). Included in this assay
is T6- which is identical to T6 except that it contains the mutated VirB binding sites from
Castellanos et al., (2009) which were shown to eliminate the VirB dependent activity of
the promoter. Our results show that VirB binds to target fragments T6 and T1 beginning
at 120 nM of VirB with complete sequestration of free DNA at 230 nM. VirB also binds
T6-, T5, T4, and T3 but at a higher concentration of 230 nM VirB. In contrast, T2 only
shifts at 460 nM, the highest concentration of VirB used, but it should be noted that even
VirB binds to the pstS negative control at this concentration. In all but this case, VirB
binding to the icsP promoter appears to be specific as evidenced by the uniform presence
of free non-specific competitor DNA in all lanes and does not shift.
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The T6- fragment, which contains the mutated essential VirB binding sites identified
in our in vivo studies (Table 1), shows a defect in the ability to bind VirB when compared
to the wild type T6 (the shift with T6 starts at 120 nM of VirB, while T6- shows a
moderate shift with 230 nM VirB). These data suggest VirB may have some affinity to
other sequences contained within this fragment, at least in vitro and under the conditions
used. Nevertheless, these results support our hypothesis that VirB interacts directly with
the upstream intergenic region of icsP and supports our observation that sequences
located over 1 kb upstream of the annotated transcription start site are required for the
VirB dependent de-repression of the icsP promoter.
Target T1, which contains sequences located between 213 and +24 relative to the
transcription start site, also shifted with low concentrations of protein. The binding of
VirB to this region of DNA may explain the VirB dependent decrease in icsP promoter
activity observed at the shortest promoter construct in our in vivo assays. The binding of
VirB to sequences contained within this region may have disrupted an H-NS induced
structure that increased promoter activity (Harrison et al., under revision; Fig. 14).
Putative VirB binding sites have been found in this region, and these EMSA data,
combined with the observations made in vivo, suggest VirB binds to these binding sites to
antagonize H-NS in vivo, although this still needs to be tested. Interestingly, VirB binds
to similar fragments of the icsP upstream intergenic region as H-NS (Harrison et al.,
under revision).
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VirB binds sequences within the intergenic region upstream of the annotated icsP
transcription start site.
DNase I footprints were used to test the hypothesis that VirB binds to the upstream
intergenic region of icsP. The same 6 fragments of the icsP upstream intergenic region
used in the EMSA were incubated with increasing concentrations of purified VirB (250
nM, 500 nM, and 1 µM). We predicted that VirB would clearly bind the DNA fragments
identified in the EMSAs, in particular T6, and T1. Consistent with our previous in vitro
experiments, (Fig. 20), VirB bound to all 6 targets (Fig. 21), however, protection was
observed with the lowest concentration of VirB (250 nM, lane 1) in targets T1, T5 and T6
suggesting that VirB binds more efficiently to sequences contained in these fragments
(results are summarized in Table 2).
Target T1 shows VirB-dependent protection at a concentration of 500 nM VirB,
before the complete protection of DNA at 1 µM. Interestingly, no hypersensitive bands
were observed when T1 was incubated with VirB, which would be indicative of a
discrete DNA-protein interaction. Instead large regions of DNase I protection are
observed in T1, strongly suggesting VirB oligomerizes along the DNA, preventing
DNase I access. VirB was observed to bind to sequences in T1 between +10 and -33 with
respect to the tss. Contained within this region are two sequences that display good
matches to the consensus VirB binding site 5’-(A/G)(A/T)G(G)AAAT-3’ (Turner &
Dorman, 2007, Taniya et al., 2003). One surrounds the transcription start site (+1) and
the other lies between -15 to -21 (although in this case the matching sequence lies in the
opposite orientation (3’-5’) to the reported consensus).
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Table 2. Summary of VirB DNase I footprints
Target

Result

T1

VirB bound at 500 nM; full protection at 1 µM; no hypersensitive sites
Bands fade with 500 nM VirB, but not much more with 1 µM; no

T2

hypersensitive sites; VirB bound to 3 regions (-201 to -274; -296 to -337;
and upstream of -347)
VirB binds 2 regions; intensity of upper region remains same while lower

T3
T4

region changes between 250 µM and 500 µM
Small regions of protection with VirB; no hypersensitive sites
Protection of bands lower in the gel at 250 nM; top arrow fades out (*-829),

T5

while bottom arrow fades in (-896; hypersensitive) indicating a protein
induced structural distortion
Footprint changes at 1 µM VirB compared to 250 nM and 500 nM, with

T6

bands shifting up and fading out
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Fig. 21. VirB binds the intergenic region of icsP. DNase I footprints were conducted using
approx. 200 nM of each fragment shown in Fig.19, and increasing concentrations of purified Histagged VirB. The concentrations of purified protein as well as the target fragment used are given
above each lane. A Maxam-Gilbert G+A ladder is included as well as position of relevant bp given
relative to the tss. The most distal (-1130 to -1145) VirB binding sites are given labeled Box 2, Box
1. Red bars indicate regions of protection. * = bands protected by increasing protein concentration.
Black arrow -896 indicates hypercleavable site. 1=250 nM VirB; 2=500 nM VirB; 3=1 µM VirB.
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Our data strongly suggest that these sites are true VirB binding sites, although site
directed mutagenesis of these sites will be needed to confirm this.
A second long region of protection can be observed extending upstream of position
-48. This is indicative of oligomerization. Strikingly, the protection observed in T1 is
more pronounced compared to the other targets, which could help explain why this target
shifts so well with low concentrations of VirB in our EMSAs (Fig. 20).
In target T5, VirB bound at low concentrations (250 nM) to sequences -829 to -896,
and to sequences upstream of -903 (sites marked with * indicate specific bases of interest
as being protected by VirB at low concentrations). Increasing concentrations of VirB
resulted in a single hypercleavable site, which indicative of a protein induced structural
distortion (-896). This is consistent with the wrapping of the DNA around the protein,
leading to increased sensitivity of the DNA to the DNase I enzyme.
In target T6, VirB bound at the low concentration of 250 nM. Protection of
sequences upstream of -1095 can be visualized. Contained within T6 are the two most
distal VirB binding sites (-1130 to -1145), which we have shown to be essential in the
regulation of icsP (Castellanos et al., 2009). The footprint in T6 is unusual in that, at
high concentrations of VirB (1µM) it is possible to see protein induced distortion of the
DNA, bands are shifted up as well as fading out. The exact significance of this finding is
unknown, but the unusual appearance of this footprint suggests VirB interacted with
sequences contained within this fragment in a manner that is distinct compared to the
other target fragments, this phenomenon was observed regularly.
These data suggest that VirB binds directly to the upstream intergenic region of icsP
(both promoter distally and promoter proximally), and that VirB oligomerizes along the
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DNA, which is consistent with previous finding regarding VirB binding (Turner &
Dorman, 2007). Our findings demonstrate that VirB bound to target fragments that were
predicted to contain VirB binding sites, as well as sequences that do not contain any
matches to the previously described VirB binding consensus sequence (e.g. T5). This
raises the possibility that VirB binds to sequences other than its consensus site, at least in
vitro, and under these conditions. Interestingly, but not surprisingly, the regions
displaying VirB binding overlap with those shown to be protected by H-NS (Fig. 22).
Overlapping, or similar, protein binding regions is a common feature among silencing
and anti-silencing proteins (Navarre et al., 2006). Taken together these data support our
model for the regulation of icsP involving the interaction of VirB with sequences located
both, promoter distally and promoter proximally, which likely displaces H-NS, resulting
in a permissive structure for transcription, possibly a loop structure. DNA looping has
been established as a mechanism of regulation at promoters where interactions involving
upstream and downstream regions bound by protein have been observed, and it is likely
that icsP is no different (De la Cruz et al., 2009, Prosseda et al., 2004). It should be
remembered that these in vitro data, with short, linear fragments of DNA, may or may not
adequately reflect the action of VirB in vivo.
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H-NS binds sequences within the intergenic region upstream of the annotated icsP
transcription start site.
We also predicted that H-NS would bind the regions identified in Harrison et al.,
(under revision), by EMSAs, in particular, to sites located within targets T5, T4 and T1.
Our results demonstrate H-NS bound to all 6 targets (Fig. 22); however, protection was
observed with the lowest concentration of H-NS (250 nM, lane 1) in targets T1, T4, T5,
and T6 (results are summarized in Table 3).
T1 shows H-NS-dependent protection within 2 regions at a concentration of 250 nM
H-NS, before the complete protection of DNA at 1 µM. H-NS bound to sequences in T1
between +10 upstream of the transcription start site and -33 bp downstream of the tss
before complete oligomerization and protection of the entire region upstream of -48.
Table 3. Summary of H-NS DNase I footprints
Target

Results

T1

H-NS bound at low concentration (250 nM); no hypersensitive sites

T2

H-NS binds 4 regions; Bands fade at 500 nM H-NS

T3

Bands fade at low concentration; bands fade faster in bottom part of gel

T4

H-NS binds 5 regions at low concentration (250 nM); 1 hypersensitive site
upstream of -618 indicating a protein induced structural distortion

T5

H-NS binds at low concentration (250 nM); 2 hypersensitive sites (-829
and -896) indicating a protein induced structural distortion

T6

Protected bands fade out at the bottom of the gel; distortion of protected
bands similar to VirB
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In T4, H-NS bound to 5 regions within the fragment at low concentrations,
corroborating our EMSA data (Fig. 16). There is the presence of a hypercleavable site
upstream of -618 indicating a protein induced structural distortion consistent with the
wrapping of the DNA around the protein. Two hypercleavable sites are also present in
T5.
In target T5, H-NS bound at the low concentration of 250 nM to a region upstream of
-903. Surprisingly, the sites (-829 and -896; black arrows in Fig. 21) which were
observed in T5 using VirB are again present with the H-NS protein (however with H-NS
both are hypercleavable) indicating a protein induced structural distortion leading to
increased sensitivity of the DNA to DNase I.
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Fig. 22. H-NS binds the upstream intergenic region of icsP. DNase I footprints were conducted using
approx. 200 nM of each fragment shown in Fig.19, and increasing concentrations of purified His-tagged HNS. The concentrations of purified protein as well as the target fragment used are given above each lane. A
Maxam-Gilbert G+A ladder is included as well as position of relevant bp given relative to the transcription
start site. The most distal VirB binding sites (-1130 to -1145) are given labeled Box 2, Box 1. Red bars
indicate regions of protection. Black arrows indicate hypercleavable sites. 1=250 nM H-NS; 2=500 nM H-NS;
3=1 µM H-NS.
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In target T6 H-NS bound to the same region as did VirB. Again, at high protein
concentration (1 µM) a distortion of the DNA is visible, similar to VirB. Despite the
striking similarities between VirB and H-NS protection signals in all the targets
examined, there are many subtle differences in the footprints with both proteins, e.g.
extended region of binding by H-NS in T4 compared to VirB.
In summary, these results demonstrate that H-NS binds directly to the upstream
intergenic region of icsP and demonstrates the ability of H-NS to oligomerize along
DNA, which is consistent with previous findings regarding H-NS function (Bouffartigues
et al., 2007, De la Cruz et al., 2009, Dorman, 2004, Dorman, 2009a, Fang & Rimsky,
2008, Navarre et al., 2006, Stoebel et al., 2008). The hypercleavable sites in T4 and T5
suggest that H-NS binding produces a conformational change in the DNA that is
responsible for the H-NS induced repression. Our data also show that H-NS binds to
promoter proximal sequences and further supports our model for the regulation of icsP
involving DNA looping and interaction with promoter distal and promoter proximal
sequences being bound by H-NS (Chapter 3, Discussion). Again H-NS bound to
sequences that overlap regions occupied by VirB highlighting the molecular antagonism
that exists between the two.
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Alteration of curvature does not effect the ability of H-NS to repress promoter
activity nor does it effect the ability of VirB to alleviate repression.
H-NS has been shown previously to bind to DNA with high intrinsic curvature and
our previous findings demonstrate that both H-NS and VirB bind to similar regions
within the icsP upstream intergenic region. Using MUTACURVE
(http://132.248.32.45/cgi-bin/mutacurv.cgi) to profile and predict the intrinsic curvature
of the icsP upstream intergenic region, we have found 5 peaks displaying curvature
values greater than 5 degrees/helical turn indicating a high degree of curvature (shown in
Fig. 23). The advantage of using MUTACURVE is that it allows the in silico evaluation









Fig. 23. In silico analysis of the static curvature of the DNA in the intergenic region of icsP.
MUTACURVE predictions of curvature showing the 5 peaks with the highest predicted intrinsic curvature
labeled below. >5 degrees/helical turn = curved (red line)  marks the peaks of highest intrinsic
curvature. Numbers below give positions of curvature relative to the tss (+1).

of the effect that double point mutations have on the effect of curvature; to either
disrupt/reduce or to restore curvature. In order to examine the effect that this curvature
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has on the regulation of icsP we adopted a strategy similar to that of De la cruz et al.
(2009), making double point mutations to disrupt/reduce the curvature surrounding the
peaks identified previously (Harrison et al., under revision; Fig. 19; Fig. 23).

Table 4. Substitutions to disrupt curvature
Postition of
curved
region

Predicted curvature
value (deg/helix turn)
prior to substitution

Predicted curvature
value (deg/helix turn)
following substitution

Base pair
substitutions
responsible

-842

9.65

4.82

A>C at -876 &
C>A at -880

-935

9.36

5.19

G>T at -968 &
A>C at -874

-663

8.09

2.67

C>A at -961 &
T>G at -696

-435

7.88

2.99

T>G at -454 &
A>C at -463

The mutations that were predicted to affect DNA curvature in silico were introduced
into the wild type icsP upstream intergenic region upstream of +1. Each of the predicted
peaks of curvature were disrupted separately by site directed mutagenesis before a second
round of mutations was introduced to restore the predicted curvature without restoring the
DNA to the original, wild type, sequence Table 2 and 3 (the predicted curvature
surrounding the tss was not mutated). The mutated sequences were cloned into the lacZ
reporter plasmid used previously (Appendix 1) and transformed into either E. coli (wild
type and a strain lacking hns) or Shigella (wild type and a strain lacking virB). We
expected that mutation of one of the regions of curvature would affect the ability of H-NS
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Table 5. Substitutions to restore curvature
Position
of curved
region

Predicted
curvature value
(deg/helix turn)
prior to
substitution

Predicted
curvature value
(deg/helix turn)
following
substitution

Predicted
curvature value
(deg/helix turn)
following
substitution

Base pair
substitutions
responsible

-842

9.65

4.82

7.86

C>T at -876 &
A>G at -880

-935

9.36

5.19

7.05

T>C at -968 &
C>T at -974

-663

8.09

2.67

6.63

A>G at -691 &
G>A at -696

-435

7.88

2.99

5.18

G>A at -454 &
C>T at -463

to silence, and VirB to anti-silence, promoter activity, thereby revealing the sequences
required for the regulation of the promoter.
Results of the β-galactosidase assay are given in Fig. 24. Surprisingly, comparing
wild type (WT) to both, mutated and restored constructs, it is clear that substitutions
predicted to disrupt curvature in each of the 4 regions had no effect on either: 1) promoter
activity in the presence or absence of H-NS or 2) promoter activity in the presence and
absence of VirB.
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Fig. 24. Activities of the curve disrupted icsP promoter fragments. Activities of the curve disrupted
promoter fragments in the presence and absence of a) H-NS or b) VirB. Constructs are labeled
according to the predicted position of curvature upstream of the transcription start site in order from
highest to lowest predicted curvature. Bars indicate β-galactosidase expression of the PicsP-lacZ
fusions in either a) wild type E. coli MC4100 and an isogenic strain lacking hns (MC4100 hns::Knr) b)
wild type S. flexneri 2457T and an isogenic strain lacking virB (AWY3 virB::Knr). WT icsP (pHJW20)
is included in each lane for comparison. β -galactosidase activities are expressed in Miller units. This is
a representative assay and error bars represent the mean and standard deviations.
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It is possible that double point mutations intended to disrupt the curvature of one
single peak have no effect given the overall length of the upstream intergenic region
(1232 bp), where another curved region may compensate for the reduced curvature of an
adjoining region simply because of the plasticity of such a large A-T rich fragment of
DNA. It is also possible that computer software might not be able to accurately predict
the curvature of DNA. We are following up these experiments to test whether these
regions are curved using biochemical tests, as described by Prosseda et al. (2004).
It is possible that mutations made to disrupt multiple curved regions may have a
greater effect on H-NS and VirB function by: i) possibly reducing the ability of the
proteins to bind to icsP, ii) by reducing the ability of the upstream regions to interact with
downstream regions, iii) or a combination of the two. Future studies will address this
concern, by disrupting multiple regions of curvature in combination, to elucidate a
complete model of transcriptional regulation involving icsP, and these studies will frame
the basis for future work.
4.4 Conclusion
In conclusion, this study furthers our understanding of the mechanism of
transcriptional regulation with the Shigella icsP gene, and raises several questions that
are central to virulence gene expression in Shigella and other enteric pathogens and
which lie at the heart of bacterial physiology. How do VirB and H-NS interact in the full
context of the upstream intergenic region of icsP? In the absence of a consensus
sequence, how is H-NS able to recognize DNA? What effect does curvature play on the
H-NS dependent silencing and VirB dependent anti-silencing of icsP? These questions,
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and many more, will need to be answered in order to achieve a complete picture of the
mechanism of transcriptional silencing and anti-silencing.
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CHAPTER 5
CONCLUSION
In this work I have focused on the regulation of the icsP gene, and examined the roles
that H-NS and VirB play in the mechanism of silencing and anti-silencing at this
promoter. This chapter addresses experiments that focus on five objectives. The first
objective was to identify regions of the icsP promoter required for H-NS mediated
repression and VirB dependent de-repression of the promoter. As a starting point for this
work I conducted a promoter deletion analysis. While these experiments do not prove that
either protein interacts directly with the icsP promoter, they allowed me to identify
regions of the promoter needed for the VirB and, to some extent H-NS, dependent
regulation of the icsP promoter. These regions could then be further interrogated using
Electrophoretic Mobility Shift Assays (EMSAs), the second objective. The third
objective was to determine the sequences to which H-NS and VirB bound in vitro. The
fourth objective was to examine the effect that icsP static DNA curvature plays in the
ability of H-NS and VirB to regulate promoter activity. Finally, the fifth objective was to
propose a mechanism for the H-NS and VirB regulation of the icsP promoter.
In Chapter 2, my data show that H-NS represses icsP promoter activity and that VirB
alleviates this repression from sites located over 1 kb upstream of the annotated
transcription start site (Castellanos et al., 2009). Through deletion analysis we have also
identified a region located promoter distally, -1130 to -1144, that is required for the derepression of promoter activity. Located in this distal region are two VirB binding sites,
organized as an inverted repeat, 5’-CGGGGATTTCAGTATGAAATGAAGTA-3’(wild type
VirB boxes shown here; Table 1), that were identified in an in silico analysis, and shown
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to be absolutely required for the VirB dependent de-repression of the promoter. Our data
revealed that complete mutagenesis of the upstream binding site (box 2), the downstream
binding site (box 1) or both, resulted in complete loss of VirB dependent regulation of the
icsP promoter (Table 1). To our knowledge, this is the first evidence that VirB can
influence promoter activity from such distal sites. Although it is unusual for H-NS and
VirB to impart its effects from so far upstream of the transcription start site, our
truncation analysis of the icsP upstream intergenic region has shed light on how this
remote regulation might occur, but raises some very important questions: (i) Are other
Shigella virulence plasmid genes regulated from remote VirB binding sites? (ii) Is it
common for transcriptional silencing and anti-silencing mechanisms to employ distal
regulator binding sites?
The experiments described in Chapter 3, focus on the regulation of the icsP promoter
by H-NS. Through deletion analysis of the icsP upstream intergenic region and in vivo
assays, I, and others in the Wing lab, identified that sequences upstream of -665 (with
respect to the icsP annotated transcription start site [tss]) are needed for full H-NS
induced repression of activity the promoter, although sequences between -665 and -351
appear sufficient for partial repression. Furthermore, our data strongly suggests that HNS binds to two discrete regions (upstream of -351 and downstream of -213) in vivo, that
lie upstream of the icsP gene. This observation is backed up by in vitro EMSAs and
based on our assays it seems that these two regions are separated by a region with little to
no affinity for HNS (regions contained within T2 in Fig. 16). Both regions to which HNS binds, contain sequences predicted to display high levels of intrinsic curvature. These
data support a model where H-NS docked at remote sites may act in concert with H-NS
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docked at promoter proximal sequences to mediate H-NS-dependent repression of the
icsP promoter. While we again demonstrate that VirB functions solely to de-repress the
promoter, our EMSA data indicate that VirB and H-NS are capable of binding
simultaneously to the full intergenic region (1232 bp) that lies immediately upstream of
the icsP gene. This suggests that VirB may function to relocate H-NS, rather than
causing H-NS to dissociate from the DNA upstream of the icsP gene.
In Chapter 4, my work has demonstrated that VirB binds the upstream intergenic
region of icsP, and I have shown that both VirB and H-NS oligomerize along the DNA. I
have also investigated the role that DNA intrinsic curvature plays in the regulation of
icsP. Using electrophoretic mobility shift assays (EMSAs), and DNase I footprinting
analysis I show that VirB binds directly to the upstream intergenic region of icsP and
demonstrate that VirB and H-NS bind and oligomerize to DNA sequences located
promoter distally and proximally. From these results we conclude that both H-NS and
VirB interact directly with the icsP promoter and confirm our in vivo results
demonstrating that sequences located over 1 kb upstream of the annotated tss are required
for the H-NS dependent silencing and the VirB dependent anti-silencing of the icsP
promoter. These data support a model where VirB bound to remote sites may act in
concert with VirB bound to promoter proximal sequences to mediate VirB dependent
anti-silencing of the icsP promoter.
In Chapter 4, I also show that the disruption of single regions displaying high intrinsic
curvature do not have an effect on icsP promoter activity. These regions of predicted
curvature were mutated using site directed mutagenesis to disrupt and ultimately restore
the curvature. Surprisingly, disruption of these regions of predicted curvature did not
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have an effect on either the ability of H-NS to silence the promoter or the ability of VirB
to alleviate the H-NS induced repression. Likewise, mutations to restore the predicted
curvature had no effect. It is likely that disruption of a single peak within the context of
1.2 kb is not sufficient to elicit an effect.
Taken together, these data have allowed us to propose a model for the regulation of
icsP. At the non-permissive temperature of 30 ˚C H-NS binds and induces H-NS-DNAH-NS loops or bridges between promoter distal and promoter proximal sequences. At the
permissive temperature of 37 ˚C, the temperature at which VirB is maximally expressed,
VirB binds to its consensus site (Taniya et al., 2003, Tobe et al., 1991, Turner &
Dorman, 2007), which is AT rich and frequently lies in AT rich stretches of DNA. These
sequences likely are already bound by H-NS. We hypothesize that VirB does not
completely remove H-NS from the DNA, but instead binds simultaneously and possibly
re-organizes the DNA:protein complex by binding to promoter distal VirB binding sites
in conjunction with promoter proximal sequences bound by VirB. The nucleoprotein
complex might be stabilized through the interaction of VirB bound to sites located
internally. This multi-region DNA:protein interaction then possibly leads to a reorganization of the topology of the upstream intergenic region that is permissive for icsP
promoter activity (Fig. 25). This model should frame our future investigations.
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Fig. 25. Proposed model for the regulation of icsP by H-NS and VirB. The upstream intergenic region of
icsP (a) showing the two distal, essential, VirB binding sites (black arrows under the red box). At the nonpermissive temp of 30 °C H-NS induces repression of promoter activity by binding to sequences located
distally and proximally, resulting in a plectonemic structure stabilized by oligomerization of H-NS (b).
Upon a shift in temperature, to the permissive temperature of 37 °C, VirB is expressed and binds to icsP.
Instead of displacing H-NS, VirB binds simultaneously causing the reorganization in the topology of the
promoter, interacting with the 2 most distal VirB binding sites and promoter proximal sites. The resulting
structure is stabilized through VirB bound to internal sequences. The altered architecture of the promoter is
permissive for transcription (c). Shown is a VirB monomer; H-NS in dimeric form; bent arrow = tss.

While the work containd herein contributes to our knowledge, much more work is
required to build a complete picture of transcriptional silencing and anti-silencing at the
icsP promoter. It would be interesting to asses the contribution of all the VirB binding
sites identified in Castellanos et al. (2009) in the regulation of the icsP promoter, and to
examine whether a VirB:DNA:VirB loop is responsible for the observed effects
presented in this work. Site directed mutagenesis of combinations of putative VirB
binding sites would indicate which sequences are essential, and could be combined with
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KMNO3 footprinting to demonstrate a loop(s) is/are being formed. The intergenic region
that lies upstream of icsP is very AT rich, and typically such sequences have high
intrinsic curvature. While our initial results suggest that no single region of predicted
curvature is required it could be that disruption of multiple peaks in combination will
produce an observable effect. Therefore, it would also be interesting to assess the effect
of combinations of disrupted peaks on the ability of H-NS and VirB to regulate promoter
activity.
It would be beneficial to investigate the possibility that a multi-protein complex is
involved in icsP regulation, similar to situations described in other promoters (Browning
et al., 2000). The VirB protein is homologous to the P1 protein ParB, and the ParB
binding site, parS, shows a high degree of similarity to the icsB binding site described by
Turner & Dorman (2007) and Taniya et al. (2003) (Beloin et al., 2002, Taniya et al.,
2003, Surtees & Funnell, 2001). We have shown that the essential distal VirB binding
site in icsP shows sequence homology with both these sites (parS and icsB). An in silico
analysis of this region using the Softberry software BPROM, which analyzes bacterial
promoters, predicts an integration host factor (IHF) binding site oriented in a similar
position to that found in parS. In the parS system, IHF bends the parS site which allows
ParB to contact its specific binding motifs located on either side of the bend resulting in a
high affinity protein:DNA complex. Therefore, I have made an IHF mutant in Shigella
and preliminary data suggests the possible involvement of IHF in the regulation of
promoter activity and should be followed up (See Appendix 2 for full description). To
find other potential candidates, chemical cross-linking of proteins, followed by co-

104

immunoprecipitation should be able to pull out any proteins associating with VirB, and
likewise icsP.
Finally, a closer examination of the sequences to which VirB is able to bind might
elucidate a more complete description of a VirB binding site. Evidence for this comes
from the observation that VirB bound very well to T5 by DNase I footprint analysis, and
is worthy of further study.
In conclusion, this work has focused on the regulation of icsP and has examined the
roles that H-NS and VirB play in the mechanism of silencing and anti-silencing. This
work has shed light on the phenomenon of regulation from remote sites, yet it raises
many more questions. Does VirB function from remote sites to regulate the expression
of other Shigella virulence genes? An in silico analysis of another H-NS and VirBregulated promoter located on the Shigella virulence plasmid, icsB-ipgD (Turner &
Dorman, 2007), reveals the presence of additional putative VirB binding sites with the
most distal located at -1615, and -1464 upstream of the ipgD tss, and one located at -1625

Fig. 26. In silico analysis of the icsB-ipgD promoter region. In silico analysis reveals the presence
of additional putative VirB binding sites that show consensus sequence matches to the reported VirB
binding site. The binding sites in icsB are located at: -1625, -390, and -361 upstream of the tss. The
binding sites in ipgD are located at: -1615, -1464, and -289 upstream of the tss. Arrows show direction
of the binding site 5’ - 3.’ Binding site sequence is given below the figure. Figure is drawn to scale.
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upstream of the icsB tss, respectively (Fig. 26). Is it possible that these divergently
transcribed genes are regulated from remote sites?
Can transcription factors found in other bacteria function from remote sites to
alleviate transcriptional repression by nucleoid structuring proteins? If so, how
widespread is this phenomenon? Silencing and anti-silencing mechanisms that control
expression of virulence genes in Shigella and many other bacteria, is central to
understanding pathogenesis. However, these mechanisms are not restricted to the human
pathogens but may be more wide spread, we need only look.
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APPENDIX 1
BACTERIAL STRAINS, PLASMIDS, AND PRIMERS
Table 1 Bacterial strains and plasmids
Strain or
Descriptiona
Plasmid

Source or
Reference

Strains
E. coli
MC4100

E. coli strain K-12 with araD and lacZ deletion

MC4100 hns MC4100 hns::Knr

(Pogliano &
Beckwith, 1994)
(Yamada et al., 1991)

S. flexneri
2457T
AWY3

S. flexneri serotype 2a

(Formal et al., 1958)

2457T virB::Tn5; Knr

(Wing et al., 2004)

Plasmids
pACYC184 Cloning vector; p15A replicon Tetr/Cmr/source of
non-specific competitor DNA
pHJW7

icsP promoter region transcriptionally fused to lacZ
in pACYC184 Cmr.

pBluescript Cloning vector

(Rose, 1988)

(Wing et al., 2004)

Stratagene

pQE-60

Cloning vector for production of C-terminally Histagged proteins

Qiagen

pHJW20

pHJW7 lacking XbaI site downstream of lacZ gene.
Carries 1232 bp of native sequence upstream of the
icsP transcription start site
pHJW20 carrying 1056 bp of native sequence
upstream of the icsP transcription start site.

(Wing et al., 2004)

pHJW20 carrying 891 bp of native sequence
upstream of the icsP transcription start site.

(Castellanos et al.,
2009)

pJS01
pJS02
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(Castellanos et al.,
2009)

pDH01

pHJW20 carrying 663 bp of native sequence
upstream of the icsP transcription start site.

(Castellanos et al.,
2009)

pJS04

pHJW20 carrying 351 bp of native sequence
upstream of the icsP transcription start site.

(Castellanos et al.,
2009)

pHJW34

pHJW20 carrying 254 bp of native sequence upstream of
the icsP transcription start site.

(Castellanos et al.,
2009)

pHJW35

pHJW20 carrying 150bp of native sequence upstream of
the icsP transcription start site.

(Castellanos et al.,
2009)

pHJW36

pHJW20 carrying 92 bp of native sequence upstream of
the icsP transcription start site.

(Castellanos et al.,
2009)

pMIC01

pHJW20 with 33bp deleted between SalI and PstI sites in (Castellanos et al.,
the multiple cloning site of pACYC184 this changes the
2009)
context of the upstream icsP promoter sequences.

pMIC02

pHJW20 carrying 1437 bp of native sequence upstream
of the icsP transcription start site.

(Castellanos et al.,
2009)

pMIC13

pHJW20 with all 7 bps substituted in promoter proximal
upstream VirB binding site

(Castellanos et al.,
2009)

pMIC17

pHJW20 with all 7 bps substituted in distal upstream
VirB binding site

(Castellanos et al.,
2009)

pMIC18

pHJW20 with all 7bps substituted in both upstream VirB
binding sites

(Castellanos et al.,
2009)

pShfT1

EMSA/DNase I footprint Target#1 in pBluescript

This work

pShfT2

EMSA/DNase I footprint Target#2 in pBluescript

This work

pShfT3

EMSA/DNase I footprint Target#3 in pBluescript

This work

pShfT4

EMSA/DNase I footprint Target#4 in pBluescript

This work
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pShfT5

EMSA/DNase I footprint Target#5 in pBluescript

This work

pShfT6

EMSA/DNase I footprint Target#6 in pBluescript

This work

pAJH01

IPTG inducible vector carrying his-virB

This work

pCTH01

IPTG inducible vector carrying his-hns

This work

pBAD18

L-arabinose inducible pBAD expression vector, pBR
ori; Ampr

pATM324

pBAD18-virB; Ampr

(Guzman et al.,
1995)
((Schuch et al, 1999)

pNEO1

PstI, XbaI insert of icsP cloned into pBluescript.
Carries 1232 bp of native sequence upstream of the
icsP transcription start site. Used as template for sitedirected mutagenesis

This work

pMut1 D

pHJW20 with 2bp substitution to disrupt curvature at 842
A>C at -876 & C>A at -880 relative to icsP tss.

This work

pMut2 D

pHJW20 with 2bp substitution to disrupt curvature at 935
G>T at -968 & A>C at -974 relative to icsP tss.

This work

pMut3 D

pHJW20 with 2bp substitution to disrupt curvature at 663
C>A at -691 & T>G at -696 relative to icsP tss.

This work

pMut4 D

pHJW20 with 2bp substitution to disrupt curvature at 435
T>G at -454 & A>C at -463 relative to icsP tss.

This work

pMut1 R

pHJW20 with 2bp substitution to restore curvature at 842
C>T at -876 & A>G at -880 relative to icsP tss.

This work

pMut2 R

pHJW20 with 2bp substitution to restore curvature at 935
T>C at -968 & C>T at -974 relative to icsP tss.

This work

pMut3 R

pHJW20 with 2bp substitution to restore curvature at 663
A>G at -691 & G>A at -696 relative to icsP tss.

This work
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pMut4 R

pHJW20 with 2bp substitution to restore curvature at 435
G>A at -454 & C>T at -463 relative to icsP tss.

This work

a

Ampr, ampicillin resistance; Tetr, tetracycline resistance; Cmr, chloramphenicol
resistance; Knr, kanamycin resistance
Table 2 Oligonucleotide Primers
Primer

Sequencea 5'-3'

W1016

CAGATAAAATATTTCAAGATTTCAGTGC

W1017

CCCGCATCCACAGGACGGGTGTGGTCG

W1018

GTGAGAGGGCCGCGGCAAAGCC

W530

GGGTACCTGCAGTAAAAGATATGTTCTTGG

W44

GGGTACCTGCAGGCCTCTTTATTATAAGTAAGATCTGGC

W45

GGGTACCTGCAGAGTGAACTCTCGCCCTATACGGCG

W46

GGGTACCTGCAGTTTGGTCACTTTAACTGTATTAGTCGC

W47

GGGTACCTGCAGGTTGGTACTGAAAGGCACGTTGGC
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Description or
useb
Mutation of XbaI
binding site
downstream of the
lacZ gene.
Used with W1016
to create ‘mega’primer lacking
XbaI site.
Used with
‘mega’-primer to
create fragment
lacking XbaI site.
Binds to
sequences -92 to 75 relative to the
icsP tss. Used
with W48 to make
pHJW36.
Binds to
sequences -1056
to -1030 relative
to the icsP tss.
Used with W48 to
make pJS01.
Binds to
sequences -891 to
-868 relative to
the icsP tss. Used
with W48 to make
pJS02.
Binds to
sequences -663 to
-637 relative to
the icsP tss. Used
with W48 to make
pDH01.
Binds to
sequences -351 to
-328 relative to
the icsP tss. Used
with W48 to make
pJS04.

W528

W529

W530

W63

W144

W65

W145

W67

W157

GGGTACCTGCAGGGCGAGAGAACAAGAAGGTGAGTAG

GGGTACCTGCAGCTTTATTCGCACAATGAGG

GGGTACCTGCAGTAAAAGATATGTTCTTGG

Binds to sequences 254 to -241 relative to
the icsP tss. Used with
W48 to make
pHJW34.
Binds to sequences 150 to -132 relative to
the icsP tss. Used with
W48 to make
pHJW35.
Binds to sequences -92
to -75 relative to the
icsP tss. Used with
W48 to make
pHJW36.

TGAGACGTCGACAGAACTCTACTTTTTTGGTTGAAATGTCC

Binds to sequences -3
to +24. Used to make
icsP promoter
Target#1 Reverse

CCGGGAATTCTTGTCGCGGAATCCTGAAACTATCAGCC

Binds to sequences 227 to -200. Used to
make icsP promoter
Target#1 Forward

TGAGACGTCGACTCATTGTGCGAATAAAGTAACGGGGGC

Binds to sequences 160 to -134. Used to
make icsP promoter
Target#2 Reverse

CCGGGAATTCAGGTTGTCATGTTGTGACTGAAAGGC

Binds to sequences 361 to -336 . Used to
make icsP promoter
Target#2 Forward

TGAGACGTCGACCGATAAGACAATAAATTGTCATCACGGC

Binds to sequences 320 to -293. Used to
make icsP promoter
Target#3 Reverse

CCGGGGATCCTCTGACTCTCGACTTTAAAAGGATGGG

Binds to sequences 635 to -608 . Used to
make icsP promoter
Target#3 Forward
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W69

W147

W71

W148

W73

W149

TGAGACGTCGACGGGCACCTCACTTTAGCACTGAAGCC

Binds to sequences 548 to -523 . Used to
make icsP promoter
Target#4 Reverse

CCGGGAATTCGCGTTTTCAAGGATTAGTCCTTAATCGG

Binds to sequences 870 to -843 . Used to
make icsP promoter
Target#4 Forward

TGAGACGTCGACAATAAATATTCTACTAATTTAATGCATCAC

Binds to sequences 759 to -730 . Used to
make icsP promoter
Target#5 Reverse

CCGGGAATTCAAGCCTCTTTATTATAAGTAAGATCTGGC

Binds to sequences 1058 to -1030 . Used
to make icsP
promoter Target#5
Forward

TGAGACGTCGACCAATAAAATGGTTGGTTGAAGGTCGTG

Binds to sequences 995 to -969. Used to
make icsP promoter
Target#6 Reverse

CCGGGAATTCATGCTTGATAACTTAATTGGGGCTCCC

Binds to sequences 1214 to -1188. Used
to make icsP
promoter Target#6
Forward

W81

ATGTTTATGATACCTGCAGG

W82

AGGACTTCCGTCGACCAGGAAATAGTGCGGGCAAC

W89

CAAATTATCTAGAAAAGATCGCAGG
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Binds to sequences 1219 to -1232 relative
to the icsP tss. Used to
amplify sequences
contained in pMIC02.
Binds to sequences 1473 to -1454 relative
to the icsP tss. Used to
amplify sequences
contained in pMIC02.
Binds downstream of
the transcription start
site in icsP gene. Used
in the construction of
pMIC13, 17 & 18.

W98

W99

W100

W101

CCCGTTCCATGTGCTCGCC

Binds to pACYC184
upstream of cloned
sequences. Used in the
construction of
pMIC13, 17 & 18.

/5Phos/ACTGAAATCCCCGGAAGTATTCAATC

Binds to promoter
proximal upstream
VirB binding site; wild
type sequence. Used in
the construction of
pMIC17.

/5Phos/AGCTGGGCCCCCGGAAGTATTCAATC

Binds close to
promoter proximal
upstream VirB binding
site used to mutate this
sequence. Used in the
construction of
pMIC13 & 18.

/5Phos/ATGAAATGAAGTATATTTAATATACTTTAC

Binds to distal
upstream VirB binding
site; wild type
sequence. Used in the
construction of
pMIC13.

W110

/5Phos/CGACCCGGAAGTATATTTAATATACTTTAC

W149

CCGGGAATTCATGCTTGATAACTTAATTGGGGCTCCC

W75

CCGGGAATTCTCAATGAAATTGCTAATT

W76

W77

CCGGGAATTCATGCAATCCCAAATTAGT

TGAGACGTCGACCCACTCTTCGTTCACTTTCGCC
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Binds close to distal
upstream VirB binding
site used to mutate this
sequence. Used in the
construction of
pMIC17 & 18.
Binds to
sequences -1214
to -1188. Used to
make icsP
promoter
Target#6 Forward
icsB positive control
Reverse (Turner &
Dorman, 2007)
icsB positive control
Forward (Turner &
Dorman, 2007)
pstS negative
control Forward
binds internal to
translation start
site

W78

GTGTCAGTCGACCTCAGGAAGGTCTGTTCCAGTTCCC

W108

GTGTCAGTCGACTATTGGTCTTCCACGCAGCGC

W109

GTGTCAGTCGACTTATGAAAGTTATGCGTACCACCG

W38

CAGGGTGTGCCATGGTGGATTTGTGC

W39

CAGCTAATTAAGCTTAGTGATGGTGATGGTGATGTCCTGAAGAC
GATAGATGGC

W134

TCATTCCCATGGCCGAAGCACTTAAAATTCTGAAC

W135

TCATTCAGATCTTTGCTTGATCAGGAAATCGTCG

W112

CGCATTGTTAGATTTCATACACGG

W113.1

AAATGTAGCACCTGAAGTCAGCC

W206

TCCTTGAAAACGCCGTATCGGGAGAGAGTTCACTCTATTG

pstS negative
control Reverse
binds internal to
translation start
site
pstS' negative
control Reverse
orf
pstS' negative
control Forward
orf
Used to clone
virB into pQE60
Used to clone
virB into pQE60
Used to clone hns
into pQE60
Used to clone hns
into pQE60
Reverse primer
binds downstream
of ClaI in
pACYC184 used
to make nonspecific
competitor DNA.
Forward primer
binds upstream of
ClaI in
pACYC184 used
to make nonspecific
competitor DNA.

Forward primer
to disrupt
curvature at 842 relative to the
icsP tss

W207

CAATAGAGTGAACTCTCTCCCGATACGGCGTTTTCAAGGA

Reverse primer
to disrupt
curvature at 842 relative to the
icsP tss

W208

CCACTACTGAACTATTCTGGGATTTAAATTCAATACAATGGTTG
GTTGAAGGTC

Forward primer
to disrupt
curvature at 935 relative to the
icsP tss
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W209

GACCTTCAACCAACCATTGTATTGAATTTAAATCCCAGAATAGT
TCAGTAGTGG

Reverse primer
to disrupt
curvature at 935 relative to the
icsP tss

W210

GTTATCCTCTACACATTTTATCTAATGTGTACTTGGACAATTCA
TTGGTGC

Forward primer
to disrupt
curvature at 663 relative to the
icsP tss

W211

GCACCAATGAATTGTCCAAGTACACATTAGATAAAATGTGTAGA
GGATAAC

Reverse primer
to disrupt
curvature at 663 relative to the
icsP tss

W212

GTATAGTTTTTCAGATTTTGTTTGTCCCGTGACATATTATGGAA
ATGGCAGAAGCA

Forward primer
to disrupt
curvature at 435 relative to the
icsP tss

W213

TGCTTCTGCCATTTCCATAATATGTCACGGGACAAACAAAATCT
GAAAAACTATAC

Reverse primer
to disrupt
curvature at 435 relative to the
icsP tss

W214

TCCTTGAAAACGCCGTATTGGGGGAGAGTTCACTCTATTG

Forward primer
to restore
curvature at 842 relative to the
icsP tss

W215

CAATAGAGTGAACTCTCCCCCAATACGGCGTTTTCAAGGA

Reverse primer
to restore
curvature at 842 relative to the
icsP tss

W216

ACTACTGAACTATTCTGGGATTTAAATCCAATATAATGGTTGGT
TGAAGGT

Forward primer
to restore
curvature at 935 relative to the
icsP tss

W217

ACCTTCAACCAACCATTATATTGGATTTAAATCCCAGAATAGTT
CAGTAGT

Reverse primer
to restore
curvature at 935 relative to the
icsP tss

W218

GTTATCCTCTACACATTTTATCTGATGTATACTTGGACAATTCA
TTGGTGC

Forward primer
to restore
curvature at 663 relative to the
icsP tss
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W219

GCACCAATGAATTGTCCAAGTATACATCAGATAAAATGTGTAGA
GGATAAC

Reverse primer
to restore
curvature at 663 relative to the
icsP tss

W220

GTATAGTTTTTCAGATTTTGTTTATCCCGTGATATATTATGGAA
ATGGCAGAAGCA

Forward primer
to restore
curvature at 435 relative to the
icsP tss

W221

TGCTTCTGCCATTTCCATAATATATCACGGGATAAACAAAATCT
GAAAAACTATAC

Reverse primer
to restore
curvature at 435 relative to the
icsP tss

a

Restriction sites underlined.

b

tss, transcription start site.

c

Bold indicates bases mutated by site directed mutagenesis
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APPENDIX 2
PRELIMINARY EXAMINATION OF THE INVOLVEMENT OF IHF IN THE
REGULATION OF THE ICSP PROMOTER

The VirB protein is homologous to the P1 protein ParB, and the ParB binding site,
parS, shows a high degree of similarity to the icsB binding site described by Turner &
Dorman (2007) and Taniya et al. (2003) (Beloin et al., 2002, Taniya et al., 2003, Surtees
& Funnell, 2001). We have shown that the essential distal VirB binding site in icsP
shows sequence homology with both these sites (parS and icsB). An in silico analysis of
this region using the Softberry software BROM, which analyzes bacterial promoters,
predicts an integration host factor (IHF) binding site oriented in a similar position to that
found in parS (Fig. 27).

Fig. 27. Comparison of P1 parS and icsP. Comparison of the P1 parS and icsP sites showing the ParB
binding sites in parS (upper) and the VirB binding sites in icsP (lower). The IHF binding site is shown for
parS and the BPROM predicted IHF site is shown in icsP. parS (Surtees & Funnell, 2001).

Based on this finding, I conducted a preliminary experiment to assess the potential
contribution that IHF makes in the regulation of icsP promoter. IHF exists as a
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heterodimeric sequence specific DNA binding protein and functions as both a structural
element in the cell and as a conventional regulator of gene expression. The two subunits
of the protein are encoded by the chromosomal genes himA and himB (also seen in the
literature as ihfA and ihfB) (Funnell, 1988). Its role is to bend DNA up to 180° which
facilitates the formation of nucleoprotein complexes. IHF is a positive regulator of both
virF and virB (Porter & Dorman, 1997).
Through P1 transduction I introduced a tetracycline resistance cassette into the himA
gene of Shigella flexneri 2a, wild type and an isogenic strain lacking virB, to ablate the
function of the IHF protein. Similar strategies have been used to disrupt IHF function
since IHF exists as a heterodimeric protein; disruption of either gene is sufficient to
destroy function (Funnell, 1988). These cells were transformed with our reporter plasmid
containing the full upstream intergenic region of icsP::lacZ and assayed in the βgalactosidase assay (described in materials and methods, chapters 2, 3 and 4). The results
in Fig. 28 suggest that IHF does not play a role in the VirB dependent regulation of icsP
promoter activity.
In the parS system, IHF bends the parS site which allows ParB to contact its specific
binding motifs located on either side of the bend resulting in a high affinity protein:DNA
complex. However, in the absence of IHF, ParB binds specifically, but more weakly to
parS and only requires the right half of the parS site for activity (Vecchiarelli et al,
2007). Therefore, it could be possible that in our reporter system the absence of IHF is
not sufficient to produce a defect in the ability of VirB to regulate promoter activity, in
fact, the data suggests that in the absence of himA- the presence of VirB increases
promoter activity above what is seen in the wild type. Could this be evidence for IHF
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participation in promoter regulation? It is an interesting finding that bears further
investigation. It would be interesting to investigate the interaction between VirB, H-NS,
and IHF. An E. coli MC4100 himA- construct has been made, however, the hns-, himAdouble knock out has been difficult to create as this is likely deleterious to the cell, but
the potential information that could be gained from demonstrating a mulit-nucleoprotein
complex in the regulation of icsP would be worth the effort.

Fig. 28. IHF does not regulate icsP promoter activity. β-galactosidase assay of the full upstream
intergenic region of icsP::lacZ (pHJW20). Bars indicate β-galactosidase expression in the presence and
absence of virB, himA and the double mutant lacking both. β-galactosidase activities are expressed in
Miller units and mean and standard deviations are shown. This graph is a representative sample.
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